All Stories

  1. PSMA Theranostics in Prostate Cancer and Beyond: Current and Future Perspectives

    Article • Cancers, November 2025, MDPI AG

    Professor Nathan Lawrentschuk

  2. Scribe smarter, not harder: how artificial intelligence scribes stack up against human clinicians

    Article • BJU International, October 2025, Wiley

    Professor Nathan Lawrentschuk

  3. The role of PSMA PET/CT in staging patients with intermediate‐risk prostate cancer

    Article • BJU International, September 2025, Wiley

    Professor Nathan Lawrentschuk

  4. End of the TRUS era: transperineal biopsy takes the lead in prostate cancer detection

    Article • Nature Reviews Urology, September 2025, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  5. New evidence and novel techniques for assessing intraoperative margins during radical prostatectomy

    Article • Nature Reviews Urology, September 2025, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  6. Quality of information on Hypospadias from artificial intelligence chatbots: how safe if AI for patient and family information?

    Article • Journal of Pediatric Urology, September 2025, Elsevier

    Professor Nathan Lawrentschuk

  7. Perioperative chemotherapy use and related outcomes in muscle‐invasive bladder cancer in Australia

    Article • BJUI Compass, September 2025, Wiley

    Professor Nathan Lawrentschuk

  8. PSMA PET in Favourable Intermediate-Risk Prostate Cancer? Gold Mine or Money Pit

    Article • Société Internationale d’Urologie Journal, August 2025, MDPI AG

    Professor Nathan Lawrentschuk

  9. Is Testosterone Therapy Safe for Men with Localized Prostate Cancer? A Review of Studies

    Article • BJU International, August 2025, Wiley

    Professor Nathan Lawrentschuk

  10. The Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Assessment of Local Recurrence and Distant Metastases in Patients with Biochemical Recurrence of Prostate Cancer After Definitive Treatment: A Systematic Review and Meta-an...

    Article • European Urology, August 2025, Elsevier

    Professor Nathan Lawrentschuk

  11. PSMA PET in Prostate Cancer Staging: Guideline Review for Intermediate and High-Risk Cases

    Article • BJU International, July 2025, Wiley

    Professor Nathan Lawrentschuk

  12. A meta‐analysis of Retzius‐sparing and hood‐technique robot‐assisted radical prostatectomy

    Article • BJU International, July 2025, Wiley

    Professor Nathan Lawrentschuk

  13. Evolving Treatment Trends in Node-Positive Prostate Cancer in the PSMA-PET Era

    Article • BJUI Compass, July 2025, Wiley

    Professor Nathan Lawrentschuk

  14. R.E.N.A.L. Score's Impact on Kidney Cancer Radiation Treatment Outcomes

    Article • BJU International, June 2025, Wiley

    Professor Nathan Lawrentschuk

  15. TURP vs. New Minimally Invasive BPH Treatments: An Australian Cost-Effectiveness Study

    Article • BJU International, June 2025, Wiley

    Professor Nathan Lawrentschuk

  16. A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment

    Article • European Urology, June 2025, Elsevier

    Professor Nathan Lawrentschuk

  17. Cost-utility Analysis of Navigate, a Treatment Decision Aid for Men with Prostate Cancer and Their Partners, in Comparison to Usual Care

    Article • European Urology Oncology, June 2025, Elsevier

    Professor Nathan Lawrentschuk

  18. Development of the CAMUS Intra- and Postoperative Risk and Difficulty Estimation Indices Risk Prediction Tool for Estimating Peri- and Postoperative Outcomes, Including Surgical Difficulty, in Major Urological Surgery—A Protocol for a Delphi Study

    Article • European Urology Open Science, June 2025, Elsevier

    Professor Nathan Lawrentschuk

  19. PSMA PET as a Tool for Active Surveillance of Prostate Cancer—Where Are We at?

    Article • Journal of Clinical Medicine, May 2025, MDPI AG

    Professor Nathan Lawrentschuk

  20. Active surveillance in prostate cancer: when to exit and what are the options?

    Article • BJU International, May 2025, Wiley

    Professor Nathan Lawrentschuk

  21. The Value of Artificial Intelligence in Prostate-Specific Membrane Antigen Positron Emission Tomography: An Update

    Article • Seminars in Nuclear Medicine, May 2025, Elsevier

    Professor Nathan Lawrentschuk

  22. Adrenal Anatomy and Physiology

    Article • Urologic Clinics of North America, May 2025, Elsevier

    Professor Nathan Lawrentschuk

  23. Re: Effect of NeuroSAFE-guided RARP Versus Standard RARP on Erectile Function and Urinary Continence in Patients with Localised Prostate Cancer (NeuroSAFE PROOF): A Multicentre, Patient-blinded, Randomised, Controlled Phase 3 Trial

    Article • European Urology, May 2025, Elsevier

    Professor Nathan Lawrentschuk

  24. Re: Local Anaesthetic Transperineal Biopsy Versus Transrectal Prostate Biopsy in Prostate Cancer Detection (TRANSLATE): A Multicentre, Randomised, Controlled Trial

    Article • European Urology, May 2025, Elsevier

    Professor Nathan Lawrentschuk

  25. Risk Prediction Tools for Estimating Surgical Difficulty and Perioperative and Postoperative Outcomes Including Morbidity for Major Urological Surgery: A Concept for the Future of Surgical Planning

    Article • European Urology Open Science, May 2025, Elsevier

    Professor Nathan Lawrentschuk

  26. Long‐term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatment

    Article • BJU International, April 2025, Wiley

    Professor Nathan Lawrentschuk

  27. Lutetium‐177 PSMA – the new snake oil? An Australian experience

    Article • BJU International, April 2025, Wiley

    Professor Nathan Lawrentschuk

  28. Can only AI can save us from the burden of administration?

    Article • BJU International, April 2025, Wiley

    Professor Nathan Lawrentschuk

  29. Prevalence and Medium-Term Outcomes of Patients with Biopsy-Proven Intermediate- to High-Risk Prostate Adenocarcinoma with Low Intraprostatic Uptake on [68Ga]Ga-PSMA-11 PET/CT in the proPSMA Study

    Article • Journal of Nuclear Medicine, March 2025, Society of Nuclear Medicine

    Professor Nathan Lawrentschuk

  30. An overview of renorrhaphy techniques for partial nephrectomy

    Article • International Journal of Urology, March 2025, Wiley

    Professor Nathan Lawrentschuk

  31. PSMA-Guided Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma: The Proof-of-Concept PEDESTAL Study

    Article • Journal of Nuclear Medicine, February 2025, Society of Nuclear Medicine

    Professor Nathan Lawrentschuk

  32. Mapping the Shifting Landscape of Urological Innovation

    Article • Société Internationale d’Urologie Journal, February 2025, MDPI AG

    Professor Nathan Lawrentschuk

  33. Re: Artificial Intelligence and Radiologists in Prostate Cancer Detection on MRI (PI-CAI): An International, Paired, Non-inferiority, Confirmatory Study

    Article • European Urology, February 2025, Elsevier

    Professor Nathan Lawrentschuk

  34. PSMA PET Scans Can Predict Prostate Cancer Severity and Recurrence Risk

    Article • BJU International, January 2025, Wiley

    Professor Nathan Lawrentschuk

  35. Balancing Treatment in Advanced Prostate Cancer: When to Scale Back?

    Article • BJU International, January 2025, Wiley

    kenneth chen, Professor Nathan Lawrentschuk

  36. Time to castrate the cost? the rising expense of chemical castration for the management of prostate cancer

    Article • Prostate International, January 2025, Elsevier

    Professor Nathan Lawrentschuk

  37. Safety and Feasibility of Robotic-Assisted Bladder Surgery After Radiation Therapy

    Article • BJUI Compass, December 2024, Wiley

    Professor Nathan Lawrentschuk

  38. Stereotactic Body Therapy for Urologic Cancers—What the Urologist Needs to Know

    Article • Life, December 2024, MDPI AG

    Professor Nathan Lawrentschuk

  39. Re: Updated Analysis of Comparative Toxicity of Proton and Photon Radiation for Prostate Cancer

    Article • European Urology, December 2024, Elsevier

    Professor Nathan Lawrentschuk

  40. Re: [177Lu]Lu-PSMA-617 plus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer (ENZA-p): An Open-label, Multicentre, Randomised, Phase 2 Trial

    Article • European Urology, December 2024, Elsevier

    Professor Nathan Lawrentschuk

  41. Snap Diagnosis: Developing an Artificial Intelligence Algorithm for Penile Cancer Detection from Photographs

    Article • Cancers, November 2024, MDPI AG

    Professor Nathan Lawrentschuk

  42. Cystectomy and lymphadenectomy – we now node how far to go!

    Article • BJU International, November 2024, Wiley

    Professor Nathan Lawrentschuk

  43. Common incidental urological lesions on computed tomography images: What to do with renal and adrenal computed tomography incidentalomas in a primary care setting

    Article • Australian Journal of General Practice, November 2024, The Royal Australian College of General Practitioners

    Professor Nathan Lawrentschuk

  44. Penile dermatology for the general practitioner: A pragmatic approach to diagnosis and management

    Article • Australian Journal of General Practice, November 2024, The Royal Australian College of General Practitioners

    Professor Nathan Lawrentschuk

  45. Re: Overall Survival with Adjuvant Pembrolizumab in Renal-cell Carcinoma

    Article • European Urology, November 2024, Elsevier

    Professor Nathan Lawrentschuk

  46. Predicting Biochemical Recurrence of Prostate Cancer Post-Prostatectomy Using Artificial Intelligence: A Systematic Review

    Article • Cancers, October 2024, MDPI AG

    Professor Nathan Lawrentschuk

  47. Surgical removal of lymph nodes in advanced testicular cancer: A review

    Article • BJU International, October 2024, Wiley

    Professor Nathan Lawrentschuk

  48. Fluorine-18–labelled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography or Magnetic Resonance Imaging to Diagnose and Localise Prostate Cancer. A Prospective Single-arm Paired Comparison (PEDAL)

    Article • European Urology Oncology, October 2024, Elsevier

    Professor Nathan Lawrentschuk

  49. Imaging in Renal Cell Carcinoma Detection

    Article • Diagnostics, September 2024, MDPI AG

    Professor Nathan Lawrentschuk

  50. Association between low total serum testosterone and body mass index in Australian survivors of testicular cancer: a retrospective analysis

    Article • Basic and Clinical Andrology, September 2024, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  51. Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

    Article • European Urology, September 2024, Elsevier

    Professor Nathan Lawrentschuk

  52. Re: First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX-Targeting Peptide, [68Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma

    Article • European Urology, September 2024, Elsevier

    Professor Nathan Lawrentschuk

  53. The High Cost of Routine Blood Tests After Surgery

    Article • BJUI Compass, August 2024, Wiley

    Professor Nathan Lawrentschuk

  54. Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer

    Article • Nature Reviews Urology, August 2024, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  55. Cost Effectiveness of Systemic Treatment Intensification for Metastatic Hormone-sensitive Prostate Cancer: Is Triplet Therapy Cost Effective?

    Article • European Urology Oncology, August 2024, Elsevier

    Professor Nathan Lawrentschuk

  56. Pseudoephedrine Treatment for Ejaculation Issues After Testicular Cancer Surgery

    Article • BJU International, July 2024, Wiley

    Professor Nathan Lawrentschuk

  57. AI's Potential in Analyzing PSMA PET Scans for Prostate Cancer Detection

    Article • BJU International, July 2024, Wiley

    Professor Nathan Lawrentschuk

  58. Author Correction: Advances in sliding clip renorrhaphy for partial nephrectomy

    Article • Nature Reviews Urology, July 2024, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  59. Advances in sliding clip renorrhaphy for partial nephrectomy

    Article • Nature Reviews Urology, June 2024, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  60. The highs and lows of grading intraductal carcinoma of the prostate

    Article • Journal of Clinical Pathology, June 2024, BMJ

    Professor Nathan Lawrentschuk

  61. Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)

    Article • European Urology Oncology, June 2024, Elsevier

    Dickon Hayne, Professor Nathan Lawrentschuk

  62. Clinical Consultation Guide: Nerve-sparing Techniques for Retroperitoneal Lymph Node Dissection in Testicular Cancer

    Article • European Urology Focus, May 2024, Elsevier

    Professor Nathan Lawrentschuk

  63. Clinical Practice Guide: Management of Chylous Ascites After Retroperitoneal Lymph Node Dissection

    Article • European Urology Focus, May 2024, Elsevier

    Professor Nathan Lawrentschuk

  64. Corrigendum to “RPN (Radius, Position of tumour, iNvasion of renal sinus) Classification and Nephrometry Scoring System: An Internationally Developed Clinical Classification To Describe the Surgical Difficulty for Renal Masses for Which Robotic Partial...

    Article • European Urology Open Science, May 2024, Elsevier

    Professor Nathan Lawrentschuk

  65. Tips and Tricks: Evolution of Orchidectomy

    Article • European Urology Focus, May 2024, Elsevier

    Professor Nathan Lawrentschuk

  66. The Role of Colostomy and Reconstructive Surgery in Managing Fournier's Gangrene: A Review

    Article • BJU International, April 2024, Wiley

    Professor Nathan Lawrentschuk

  67. Rectal Spacer Reduces Gastrointestinal Side Effects of Radiation Post Radical Prostatectomy

    Article • Société Internationale d’Urologie Journal, April 2024, MDPI AG

    Professor Nathan Lawrentschuk

  68. Beware of Bipolar Transurethral Resection of Prostate in Patients with Previously Inserted Metallic Prostate Stapling Devices

    Article • Société Internationale d’Urologie Journal, April 2024, MDPI AG

    Professor Nathan Lawrentschuk

  69. A critical evaluation of Optilume® BPH as a novel minimally invasive surgical treatment for the management of lower urinary tract symptoms in men

    Article • Translational Andrology and Urology, April 2024, AME Publishing Company

    Professor Nathan Lawrentschuk

  70. Cardiovascular disease risk assessment and multidisciplinary care in prostate cancer treatment with ADT: recommendations from the APMA PCCV expert network

    Article • World Journal of Urology, March 2024, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  71. Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study

    Article • European Urology, March 2024, Elsevier

    Professor Nathan Lawrentschuk

  72. Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial

    Article • The Lancet Oncology, March 2024, Elsevier

    Professor Nathan Lawrentschuk

  73. The Current Landscape of Prostate-Specific Membrane Antigen (PSMA) Imaging Biomarkers for Aggressive Prostate Cancer

    Article • Cancers, February 2024, MDPI AG

    Professor Nathan Lawrentschuk

  74. Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancer

    Article • Radiation Oncology, February 2024, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  75. The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosis

    Article • Australian Health Review, February 2024, CSIRO Publishing

    Professor Nathan Lawrentschuk

  76. Patient-Centred Pathology Reporting Improves Satisfaction and Understanding in Prostate Cancer Care

    Article • BJUI Compass, February 2024, Wiley

    Professor Nathan Lawrentschuk

  77. Corrigendum to “Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Re...

    Article • European Urology, February 2024, Elsevier

    Professor Nathan Lawrentschuk

  78. Indocyanine green in minimally and maximally invasive genitourinary cancer surgery

    Article • BJU International, January 2024, Wiley

    Professor Nathan Lawrentschuk

  79. A Systematic Review on Artificial Intelligence Evaluating Metastatic Prostatic Cancer and Lymph Nodes on PSMA PET Scans

    Article • Cancers, January 2024, MDPI AG

    Professor Nathan Lawrentschuk

  80. Case of the Month from the Peter MacCallum Cancer Centre, Melbourne, Australia: an operative approach to large renal angiomyolipoma associated with lymphangioleiomyomatosis

    Article • BJU International, January 2024, Wiley

    Professor Nathan Lawrentschuk

  81. A Systematic Review on Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET) Evaluating Localized Low- to Intermediate-Risk Prostate Cancer: A Tool to Improve Risk Stratification for Active Surveillance?

    Article • Life, January 2024, MDPI AG

    Professor Nathan Lawrentschuk

  82. Systematic Review and Meta-Analysis of Salvage Ablation for Radiation-Recurrent Localized Prostate Cancer – A Focal Therapy Society Project

    Article • January 2024, Elsevier

    Professor Nathan Lawrentschuk

  83. Lymphovascular Invasion at the Time of Radical Prostatectomy Adversely Impacts Oncological Outcomes

    Article • Cancers, December 2023, MDPI AG

    Professor Nathan Lawrentschuk

  84. ‘Case of the Month’ from Epworth Healthcare, Epworth, Australia: Fournier's gangrene following routine surgery

    Article • BJU International, December 2023, Wiley

    Professor Nathan Lawrentschuk

  85. Sustainability in urology – are we doing enough?

    Article • BJU International, December 2023, Wiley

    Professor Nathan Lawrentschuk

  86. Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement

    Article • European Urology, December 2023, Elsevier

    Professor Nathan Lawrentschuk

  87. Comparison of 18F-based PSMA radiotracers with [68Ga]Ga-PSMA-11 in PET/CT imaging of prostate cancer—a systematic review and meta-analysis

    Article • Prostate Cancer and Prostatic Diseases, November 2023, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  88. An exploration of testicular cancer survivors’ experience of ejaculatory dysfunction following retroperitoneal lymph node dissection—a sub-study of the PREPARE clinical trial

    Article • Journal of Cancer Survivorship, November 2023, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  89. CONFIRM trial: PSMA PET/CT in active surveillance for prostate cancer

    Article • BJU International, November 2023, Wiley

    Professor Nathan Lawrentschuk

  90. How prostate‐specific membrane antigen positron emission tomography is refining risk calculators in the primary prostate diagnostic pathway

    Article • BJU International, October 2023, Wiley

    Professor Nathan Lawrentschuk

  91. Case of the Month from University of Melbourne, Australia: refractory chyle leak after retroperitoneal lymph node dissection with updated algorithm

    Article • BJU International, October 2023, Wiley

    Professor Nathan Lawrentschuk

  92. Re: Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma with Limited Retroperitoneal Lymphadenopathy

    Article • European Urology, October 2023, Elsevier

    Professor Nathan Lawrentschuk

  93. Progressing Towards Same-Day Discharges After Robotic-Assisted Radical Prostatectomy; Safe and Cost Effective to Discharge Without Routine Blood Tests

    Article • Research and Reports in Urology, October 2023, Taylor & Francis

    Professor Nathan Lawrentschuk

  94. Barriers and enablers of active surveillance for prostate cancer: a qualitative study of clinicians

    Article • BJU International, September 2023, Wiley

    Professor Nathan Lawrentschuk

  95. Comparison of Robotic vs Open Cystectomy: A Systematic Review

    Article • Bladder Cancer, September 2023, IOS Press

    Professor Nathan Lawrentschuk

  96. Primary follicular lymphoma of an extraordinarily large prostate: A case report and review of the literature

    Article • Urology Case Reports, September 2023, Elsevier

    Professor Nathan Lawrentschuk

  97. Re: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence (NOSTONE)

    Article • European Urology, September 2023, Elsevier

    Professor Nathan Lawrentschuk

  98. The Pen is Mightier than the Machine ‐ Artificial Intelligence Image Generators in Urology

    Article • BJU International, August 2023, Wiley

    Professor Nathan Lawrentschuk

  99. Is genetic testing coming of age in advanced prostate cancer?

    Article • BJU International, August 2023, Wiley

    Professor Nathan Lawrentschuk

  100. A Systematic Review of Intra- and Postoperative Complication Reporting and Grading in Urological Surgery: Understanding the Pitfalls and a Path Forward

    Article • European Urology Oncology, August 2023, Elsevier

    Professor Nathan Lawrentschuk

  101. Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors

    Article • European Urology, August 2023, Elsevier

    Professor Nathan Lawrentschuk

  102. RPN (Radius, Position of tumour, iNvasion of renal sinus) Classification and Nephrometry Scoring System: An Internationally Developed Clinical Classification To Describe the Surgical Difficulty for Renal Masses for Which Robotic Partial Nephrectomy Is ...

    Article • European Urology Open Science, August 2023, Elsevier

    Professor Nathan Lawrentschuk

  103. Re: Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium

    Article • European Urology, August 2023, Elsevier

    Professor Nathan Lawrentschuk

  104. Government Funding of FDG‐PET Imaging In Rare Urological Cancers‐ Better Data, Better Outcomes.

    Article • BJU International, July 2023, Wiley

    Professor Nathan Lawrentschuk

  105. A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy

    Article • European Urology Open Science, July 2023, Elsevier

    Professor Nathan Lawrentschuk

  106. Editorial Comment

    Article • The Journal of Urology, July 2023, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  107. Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-an...

    Article • European Urology, July 2023, Elsevier

    Professor Nathan Lawrentschuk

  108. Electronic medical records – a disappointing mirage for clinicians and research

    Article • BJU International, June 2023, Wiley

    Professor Nathan Lawrentschuk

  109. NeoAdjuvant pembrolizumab and STEreotactic radiotherapy prior to nephrectomy for renal cell carcinoma (NAPSTER): A phase II randomised clinical trial

    Article • Contemporary Clinical Trials Communications, June 2023, Elsevier

    Professor Nathan Lawrentschuk

  110. US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know?

    Article • European Urology Open Science, June 2023, Elsevier

    Professor Nathan Lawrentschuk

  111. Emergence of triplet therapy for metastatic castration-sensitive prostate cancer: An updated systematic review and network meta-analysis

    Article • Urologic Oncology Seminars and Original Investigations, May 2023, Elsevier

    Professor Nathan Lawrentschuk

  112. Decade-long trends in prostate cancer biopsy and treatment within a population-based registry

    Article • BJU International, April 2023, Wiley

    Professor Nathan Lawrentschuk, Charlie Rapple (Kudos)

  113. Evolution and Implications of the Novel CAMUS Reporting and Classification System: From Rationale to End Product

    Article • European Urology Open Science, April 2023, Elsevier

    Professor Nathan Lawrentschuk

  114. New Approaches to Targeting Epigenetic Regulation in Bladder Cancer

    Article • Cancers, March 2023, MDPI AG

    Professor Nathan Lawrentschuk

  115. Point-Counterpoint: Active Surveillance in the “Real World” Has Far More Risks Than We Appreciate

    Article • The Journal of Urology, March 2023, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  116. Robotic-assisted radical prostatectomy: learning curves and outcomes from an Australian perspective

    Article • Prostate International, March 2023, Elsevier

    Professor Nathan Lawrentschuk

  117. Spontaneous Rupture of Urinary Bladder: A Systematic Review of Case Series and Reports

    Article • BJU International, February 2023, Wiley

    Professor Nathan Lawrentschuk

  118. A clinical study comparing polymer and gold fiducials for prostate cancer radiotherapy

    Article • Frontiers in Oncology, February 2023, Frontiers

    Professor Nathan Lawrentschuk

  119. Modern Active Surveillance in Prostate Cancer: A Narrative Review

    Article • Clinical Genitourinary Cancer, February 2023, Elsevier

    Professor Nathan Lawrentschuk

  120. Same day discharge for robot‐assisted radical prostatectomy: a prospective cohort study documenting an Australian approach

    Article • Australian and New Zealand Journal of Surgery, January 2023, Wiley

    Professor Nathan Lawrentschuk

  121. Salvage IRE for Radio-Recurrent Prostate Cancer: FIRE Trial

    Article • BJU International, January 2023, Wiley

    Professor Nathan Lawrentschuk

  122. Investigating PSMA-PET/CT to resolve prostate MRI PIRADS4-5 and negative biopsy discordance

    Article • World Journal of Urology, January 2023, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  123. Dysfunctional Lipid Metabolism—The Basis for How Genetic Abnormalities Express the Phenotype of Aggressive Prostate Cancer

    Article • Cancers, January 2023, MDPI AG

    Professor Nathan Lawrentschuk

  124. Following the Trend: A Comparative Analysis of Public Engagement and Funding for Annual Prostate and Breast Cancer Campaigns Using Google Trends

    Article • Anticancer Research, December 2022, International Institute of Anticancer Research

    Professor Nathan Lawrentschuk

  125. Management of Missed Ureteric Injury: A Case Report of Robotic Surgery

    Article • BJU International, December 2022, Wiley

    Professor Nathan Lawrentschuk

  126. Distant Nodes Seen on PSMA PET-CT Staging Predicts Post-Treatment Progression in Men with Newly Diagnosed Prostate Cancer—A Prospective Cohort Study

    Article • Cancers, December 2022, MDPI AG

    Professor Nathan Lawrentschuk

  127. Combination treatment in metastatic prostate cancer: is the bar too high or have we fallen short?

    Article • Nature Reviews Urology, December 2022, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  128. Synchronous vs Independent Reading of PSMA-PET and MRI in Prostate Cancer Diagnosis

    Article • BJU International, December 2022, Wiley

    Professor Nathan Lawrentschuk

  129. A Unique Urine Isolating Drape Technique for on Table Pyeloscopy Post Radical Cystectomy for a Suspected Upper Tract Lesion With an Obliterated Ureteric Orifice

    Article • Urology, December 2022, Elsevier

    Professor Nathan Lawrentschuk

  130. The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma

    Article • European Urology, December 2022, Elsevier

    Professor Nathan Lawrentschuk

  131. PSMA PET/CT Patterns of Recurrence After Mono-Brachytherapy in Men with Low and Intermediate Prostate Cancer and Subsequent Management

    Article • November 2022, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  132. Recent developments in the diagnosis and management of N1 penile cancer

    Article • Current Opinion in Urology, November 2022, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  133. Corrigendum to “The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma” [Eur Urol 2022]

    Article • European Urology, November 2022, Elsevier

    Professor Nathan Lawrentschuk

  134. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation—A Multicenter Validation Study

    Article • European Urology Focus, November 2022, Elsevier

    Professor Nathan Lawrentschuk

  135. Funding of all issues related to prostate cancer treatment should be a priority and have equal access – a key to survivorship

    Article • BJU International, November 2022, Wiley

    Professor Nathan Lawrentschuk

  136. Role for a Web-Based Intervention to Alleviate Distress in People With Newly Diagnosed Testicular Cancer: Mixed Methods Study

    Article • JMIR Cancer, October 2022, JMIR Publications Inc.

    Professor Nathan Lawrentschuk

  137. Systemic therapy in metastatic hormone-sensitive prostate cancer

    Article • Current Opinion in Supportive and Palliative Care, October 2022, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  138. Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up

    Article • Cancer Imaging, October 2022, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  139. Modern paradigms for prostate cancer detection and management

    Article • The Medical Journal of Australia, October 2022, Wiley

    Professor Nathan Lawrentschuk

  140. Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma

    Article • European Urology Open Science, October 2022, Elsevier

    Professor Nathan Lawrentschuk

  141. Focal Therapy for Prostate Cancer: Time for Consensus?

    Article • BJU International, September 2022, Wiley

    Professor Nathan Lawrentschuk

  142. Low‐grade prostate cancer should still be labelled cancer

    Article • BJU International, September 2022, Wiley

    Professor Nathan Lawrentschuk

  143. Active surveillance versus nonradical treatment for low-risk men with prostate cancer: a review

    Article • Prostate International, September 2022, Elsevier

    Professor Nathan Lawrentschuk

  144. Editorial introductions

    Article • Current Opinion in Urology, September 2022, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  145. Editorial: genetics in urology

    Article • Current Opinion in Urology, September 2022, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  146. Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society

    Article • Minerva Urology and Nephrology, September 2022, Edizioni Minerva Medica

    Professor Nathan Lawrentschuk

  147. PEDAL protocol: a prospective single-arm paired comparison of multiparametric MRI and 18F-DCPFyl PSMA PET/CT to diagnose prostate cancer

    Article • BMJ Open, September 2022, BMJ

    Professor Nathan Lawrentschuk

  148. Protocol for CAMUS Delphi Study: A Consensus on Comprehensive Reporting and Grading of Complications After Urological Surgery

    Article • European Urology Focus, September 2022, Elsevier

    Professor Nathan Lawrentschuk

  149. Rectourethral fistula following focal irreversible electroporation for prostate cancer

    Article • BMJ Case Reports, September 2022, BMJ

    Professor Nathan Lawrentschuk

  150. A meta-analysis of clinicopathologic features that predict necrosis or fibrosis at post-chemotherapy retroperitoneal lymph node dissection in individuals receiving treatment for non-seminoma germ cell tumours

    Article • Frontiers in Oncology, August 2022, Frontiers

    Professor Nathan Lawrentschuk

  151. Active surveillance versus enzalutamide for low‐risk prostate cancer – was it really a trial we needed?

    Article • BJU International, August 2022, Wiley

    Professor Nathan Lawrentschuk

  152. Nomogram predicting the probability of spontaneous stone passage in patients presenting with acute ureteric colic

    Article • BJU International, July 2022, Wiley

    Dickon Hayne, Professor Nathan Lawrentschuk

  153. Dose-escalated radiotherapy to 82 Gy for prostate cancer following insertion of a peri-rectal hydrogel spacer: 3-year outcomes from a phase II trial

    Article • Radiation Oncology, July 2022, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  154. New approaches to targeting epigenetic regulation in prostate cancer

    Article • Current Opinion in Urology, July 2022, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  155. Genetics of neuroendocrine prostate cancer: recent progress in genetic understanding is translating into therapeutic opportunities

    Article • Current Opinion in Urology, July 2022, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  156. Active involvement of nursing staff in reporting and grading complication‐intervention events—Protocol and results of the CAMUS Pilot Nurse Delphi Study

    Article • BJUI Compass, June 2022, Wiley

    Professor Nathan Lawrentschuk

  157. Dynamic Sentinel Lymph Node Biopsy for Penile Cancer: Accuracy is in the Technique

    Article • Urology, June 2022, Elsevier

    Professor Nathan Lawrentschuk

  158. Sensible government decisions on funding for imaging can change practice and deliver better care for men with prostate cancer

    Article • BJU International, June 2022, Wiley

    Professor Nathan Lawrentschuk

  159. Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genes

    Article • Journal for ImmunoTherapy of Cancer, June 2022, BMJ

    Professor Nathan Lawrentschuk

  160. PSMA PET-CT Imaging Predicts Treatment Progression in Men with Biochemically Recurrent Prostate Cancer—A Prospective Study of Men with 3 Year Follow Up

    Article • Cancers, May 2022, MDPI AG

    Professor Nathan Lawrentschuk

  161. Interrogating the Impassable: A Case Series and Literature Review of Unilateral SPECT-CT Groin Visualization in Men With Penile Cancer

    Article • Frontiers in Surgery, May 2022, Frontiers

    Professor Nathan Lawrentschuk

  162. PSMA PET‐CT Funding Grants Free Access to Superior Staging for Australian Men with Prostate Cancer

    Article • BJU International, May 2022, Wiley

    Professor Nathan Lawrentschuk

  163. Biomarkers Accurately Inform Treatment Decisions in Localised Prostate Cancer

    Article • European Urology Focus, May 2022, Elsevier

    Professor Nathan Lawrentschuk

  164. There is a Need for a Universal Language in the Reporting and Grading of Complication and Intervention Events to Ensure Comparability and Improvement of Surgical Care

    Article • European Urology, May 2022, Elsevier

    Professor Nathan Lawrentschuk

  165. Evaluating the diagnostic role of in‐bore magnetic resonance imaging guided prostate biopsy: a single‐centre study

    Article • Australian and New Zealand Journal of Surgery, April 2022, Wiley

    Professor Nathan Lawrentschuk

  166. Cribriform pattern disease over‐represented in pelvic lymph node metastases identified on 68GA PSMA‐PET/CT

    Article • BJUI Compass, April 2022, Wiley

    Professor Nathan Lawrentschuk

  167. Molecular classification of hormone‐sensitive and castration‐resistant prostate cancer, using nonnegative matrix factorization molecular subtyping of primary and metastatic specimens

    Article • The Prostate, April 2022, Wiley

    Professor Nathan Lawrentschuk

  168. Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial

    Article • European Urology, April 2022, Elsevier

    Professor Nathan Lawrentschuk

  169. A glass half‐full: positive impacts of the COVID‐19 pandemic on the delivery of public hospital urology care

    Article • BJU International, March 2022, Wiley

    Professor Nathan Lawrentschuk

  170. 3D printed patient-specific prostate cancer models to guide nerve-sparing robot-assisted radical prostatectomy: a systematic review

    Article • Journal of Robotic Surgery, March 2022, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  171. Recurrent testicular torsion post orchidopexy ‐ an occult emergency: a systematic review

    Article • Australian and New Zealand Journal of Surgery, March 2022, Wiley

    Professor Nathan Lawrentschuk

  172. Editorial Comment

    Article • The Journal of Urology, March 2022, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  173. Prostate‐specific antigen testing testing in the modern era

    Article • Australian and New Zealand Journal of Surgery, March 2022, Wiley

    Professor Nathan Lawrentschuk

  174. Large variation in conservative management of low‐risk prostate cancer in Australia and New Zealand

    Article • BJU International, February 2022, Wiley

    Professor Nathan Lawrentschuk

  175. Active Surveillance for Low-Risk Prostate Cancer: The Uphill Battles and the Unnecessary Ones

    Article • The Journal of Urology, February 2022, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  176. Re: Impact of the Implementation of the EAU Guidelines Recommendation on Reporting and Grading of Complications in Patients Undergoing Robot-assisted Radical Cystectomy: A Systematic Review

    Article • European Urology, February 2022, Elsevier

    Professor Nathan Lawrentschuk

  177. Adjuvant therapies for non-muscle-invasive bladder cancer: advances during BCG shortage

    Article • World Journal of Urology, January 2022, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  178. Effect of local steroids on urethral strictures: A systematic review and meta-analysis

    Article • Investigative and Clinical Urology, January 2022, The Korean Urological Association (KAMJE)

    Professor Nathan Lawrentschuk

  179. Critical shortage in BCG immunotherapy: How did we get here and where will it take us?

    Article • Urologic Oncology Seminars and Original Investigations, January 2022, Elsevier

    Professor Nathan Lawrentschuk

  180. NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma (NAPSTER): A Phase Ii Randomised Clinical Trial

    Article • SSRN Electronic Journal, January 2022, Elsevier

    Professor Nathan Lawrentschuk

  181. Re: Pietro Piazza, Luca Sarchi, Stefano Puliatti, Carlo Andrea Bravi, Sophie Knipper, Alexandre Mottrie. The Unsolved Issue of Reporting of Late Complications in Urology. Eur Urol 2021;80:527–528

    Article • European Urology, January 2022, Elsevier

    Professor Nathan Lawrentschuk

  182. Online urological educational material for medical students: can search engines be trusted?

    Article • BJU International, December 2021, Wiley

    Professor Nathan Lawrentschuk

  183. Complication reporting and grading: consensus with the Complication Reporting after minor and major Urological Surgery (CAMUS) collaboration

    Article • BJU International, December 2021, Wiley

    Professor Nathan Lawrentschuk

  184. The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study

    Article • European Urology, December 2021, Elsevier

    Professor Nathan Lawrentschuk

  185. On-Demand Manufacturing of Inexpensive 3D Printed Meatal Dilators During Supply Chain Disruptions

    Article • European Urology, November 2021, Elsevier

    Professor Nathan Lawrentschuk

  186. Robotic ultralow anterior resection, en bloc hysterectomy, unilateral ureterectomy and pelvic side wall clearance with selective anterior internal iliac artery resection – A video vignette

    Article • Colorectal Disease, October 2021, Wiley

    Professor Nathan Lawrentschuk

  187. Self‐reported lack of energy or feeling depressed 12 months after treatment in men diagnosed with prostate cancer within a population‐based registry

    Article • Psycho-Oncology, October 2021, Wiley

    Professor Nathan Lawrentschuk

  188. Gleason grade accuracy of transperineal and transrectal prostate biopsies in MRI-naïve patients

    Article • International Urology and Nephrology, October 2021, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  189. A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissections

    Article • World Journal of Urology, October 2021, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  190. Centralisation of complex urological surgery and understanding the three Es: is it inevitable?

    Article • BJU International, October 2021, Wiley

    Professor Nathan Lawrentschuk

  191. Current treatment options for newly diagnosed metastatic hormone-sensitive prostate cancer—a narrative review

    Article • Translational Andrology and Urology, October 2021, AME Publishing Company

    Professor Nathan Lawrentschuk

  192. Focal low dose-rate brachytherapy for low to intermediate risk prostate cancer: preliminary experience at an Australian institution

    Article • Translational Andrology and Urology, September 2021, AME Publishing Company

    Professor Nathan Lawrentschuk

  193. The Application of Theranostics in Different Stages of Prostate Cancer

    Article • Future Oncology, July 2021, Taylor & Francis

    Professor Nathan Lawrentschuk

  194. Assessment and management of haematuria in the general practice setting

    Article • Australian Journal of General Practice, July 2021, The Royal Australian College of General Practitioners

    Professor Nathan Lawrentschuk

  195. 68Ga-PSMA-PET screening and transponder-guided salvage radiotherapy to the prostate bed alone for biochemical recurrence following prostatectomy: interim outcomes of a phase II trial

    Article • World Journal of Urology, June 2021, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  196. Irreversible Electroporation for Prostate Cancer

    Article • Life, May 2021, MDPI AG

    Professor Nathan Lawrentschuk

  197. Efficacy of the novel, innovative, single‐use grasper integrated flexible cystoscope for ureteral stent removal: a systematic review

    Article • Australian and New Zealand Journal of Surgery, May 2021, Wiley

    Professor Nathan Lawrentschuk

  198. Corrigendum to “Early Online Attention Can Predict Citation Counts for Urological Publications: The #UroSoMe_Score” [Eur Urol Focus 6 (2020) 458–62]

    Article • European Urology Focus, May 2021, Elsevier

    Professor Nathan Lawrentschuk

  199. Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival

    Article • European Journal of Cancer, May 2021, Elsevier

    Professor Nathan Lawrentschuk

  200. Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study

    Article • Urologic Oncology Seminars and Original Investigations, May 2021, Elsevier

    Professor Nathan Lawrentschuk

  201. Prostate-specific Antigen Screening Using the Traditional Cutoff of 3 ng/ml: Pro

    Article • European Urology Focus, May 2021, Elsevier

    Professor Nathan Lawrentschuk

  202. Telehealth, virtual meetings and conferences in urology: ‘good’ COVID side effects

    Article • BJU International, May 2021, Wiley

    Professor Nathan Lawrentschuk

  203. Continuous bladder irrigation after transurethral resection of non‐muscle invasive bladder cancer for prevention of tumour recurrence: a systematic review

    Article • Australian and New Zealand Journal of Surgery, April 2021, Wiley

    Professor Nathan Lawrentschuk

  204. Oxytocin receptor antagonists as a novel pharmacological agent for reducing smooth muscle tone in the human prostate

    Article • Scientific Reports, March 2021, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  205. Role of PSMA PET/CT Imaging in the Diagnosis, Staging and Restaging of Prostate Cancer

    Article • Future Oncology, March 2021, Taylor & Francis

    Professor Nathan Lawrentschuk

  206. Patterns of primary staging for newly diagnosed prostate cancer in the era of prostate specific membrane antigen positron emission tomography: A population‐based analysis

    Article • Journal of Medical Imaging and Radiation Oncology, March 2021, Wiley

    Professor Nathan Lawrentschuk

  207. A phase I/II study of stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumours (RAPPORT): Clinical trial protocol

    Article • Contemporary Clinical Trials Communications, March 2021, Elsevier

    Professor Nathan Lawrentschuk

  208. Clinical Trial Protocol for LuTectomy: A Single-arm Study of the Dosimetry, Safety, and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy

    Article • European Urology Focus, March 2021, Elsevier

    Professor Nathan Lawrentschuk

  209. Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trial

    Article • European Urology, March 2021, Elsevier

    Professor Nathan Lawrentschuk

  210. Trans‐urethral snare stent removal: a novel, self‐constructed innovation for simultaneous ureteral stent removal and safety guidewire insertion

    Article • Australian and New Zealand Journal of Surgery, February 2021, Wiley

    Professor Nathan Lawrentschuk

  211. Re: Enzalutamide and Survival in Non-metastatic Castration-resistant Prostate Cancer

    Article • European Urology, February 2021, Elsevier

    Professor Nathan Lawrentschuk

  212. Re: Olaparib for Metastatic Castration-resistant Prostate Cancer

    Article • European Urology, February 2021, Elsevier

    Professor Nathan Lawrentschuk

  213. Proximal seminal vesicle displacement and margins for prostate cancer radiotherapy

    Article • Journal of Medical Radiation Sciences, January 2021, Wiley

    Professor Nathan Lawrentschuk

  214. Long‐term oncological outcomes of the Agarwal loop‐ligation technique for management of the distal ureter during laparoscopic radical nephroureterectomy

    Article • BJU International, January 2021, Wiley

    Professor Nathan Lawrentschuk

  215. Exploratory models comparing ethiodized oil-glue and gold fiducials for bladder radiotherapy image-guidance

    Article • Physics and Imaging in Radiation Oncology, January 2021, Elsevier

    Professor Nathan Lawrentschuk

  216. Renal cell carcinoma with intra-operatively identified encapsulated intra-luminal tumour extension throughout the entire ureter

    Article • Journal of Clinical Urology, December 2020, SAGE Publications

    Professor Nathan Lawrentschuk

  217. In reply: an example of the evolution of evidence in a new disease

    Article • Future Oncology, December 2020, Future Medicine

    Professor Nathan Lawrentschuk

  218. Inguinal lymph node dissection for penile cancer: a contemporary review

    Article • Translational Andrology and Urology, December 2020, AME Publishing Company

    Professor Nathan Lawrentschuk

  219. Open partial nephrectomy: current review

    Article • Translational Andrology and Urology, December 2020, AME Publishing Company

    Professor Nathan Lawrentschuk

  220. Cancer in Lockdown: Impact of the COVID-19 Pandemic on Patients with Cancer

    Article • The Oncologist, November 2020, Oxford University Press (OUP)

    Professor Nathan Lawrentschuk

  221. Understanding the diagnosis of prostate cancer

    Article • The Medical Journal of Australia, October 2020, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Professor Nathan Lawrentschuk

  222. Re: Prostate-Specific Membrane Antigen PET-CT in Patients with High-Risk Prostate Cancer before Curative-Intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomised, Multicentre Study

    Article • The Journal of Urology, October 2020, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  223. 3D Printing –An Avenue for Accessible Innovation in Urology

    Article • Journal of 3D Printing in Medicine, September 2020, Taylor & Francis

    Professor Nathan Lawrentschuk

  224. Scoping review: hotspots for COVID-19 urological research: what is being published and from where?

    Article • World Journal of Urology, September 2020, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  225. Clinical trials in urological oncology: COVID-19 and the potential need for a new perspective

    Article • World Journal of Urology, September 2020, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  226. Implications of COVID-19 on urological laparoscopic surgery

    Article • Future Oncology, September 2020, Future Medicine

    Professor Nathan Lawrentschuk

  227. COVID‐19 and urology in Australia and New Zealand: uncertain times

    Article • BJU International, September 2020, Wiley

    Professor Nathan Lawrentschuk

  228. Subinguinal orchiectomy—A minimally invasive approach to open surgery

    Article • BJUI Compass, August 2020, Wiley

    Professor Nathan Lawrentschuk

  229. Use of prostate‐specific membrane antigen positron‐emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer

    Article • BJU International, August 2020, Wiley

    Professor Nathan Lawrentschuk

  230. Future directions in advanced penile cancer – mechanisms of carcinogenesis and a search for targeted therapy

    Article • Future Oncology, July 2020, Taylor & Francis

    Professor Nathan Lawrentschuk

  231. Prostate-specific membrane antigen PET/computed tomography for staging prostate cancer

    Article • Current Opinion in Urology, July 2020, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  232. A systematic review and meta-analysis of the long-term outcomes of ileal conduit and orthotopic neobladder urinary diversion

    Article • Canadian Urological Association Journal, July 2020, Canadian Urological Association Journal

    Professor Nathan Lawrentschuk

  233. Peritoneal and port-site metastasis following robotic-assisted radical prostatectomy

    Article • Canadian Urological Association Journal, July 2020, Canadian Urological Association Journal

    Professor Nathan Lawrentschuk

  234. Robotic multivisceral pelvic resection: experience from an exenteration unit

    Article • Techniques in Coloproctology, July 2020, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  235. Detection and localisation of primary prostate cancer using 68gallium prostate‐specific membrane antigen positron emission tomography/computed tomography compared with multiparametric magnetic resonance imaging and radical prostatectomy spec...

    Article • BJU International, July 2020, Wiley

    Professor Nathan Lawrentschuk

  236. High Accuracy of PSMA PET in Initial Staging of High-Risk Prostate Cancer

    Article • Radiology Imaging Cancer, July 2020, Radiological Society of North America (RSNA)

    Professor Nathan Lawrentschuk

  237. Mesenteric metastases from mature teratoma of the testis: A case report

    Article • Asian Journal of Urology, July 2020, Elsevier

    Professor Nathan Lawrentschuk

  238. Robot-assisted ipsilateral ureteroureterostomy in a duplex system utilizing intraoperative flexible ureteroscopy

    Article • Urology Case Reports, July 2020, Elsevier

    Professor Nathan Lawrentschuk

  239. Intermittent versus continuous androgen deprivation therapy for advanced prostate cancer

    Article • Nature Reviews Urology, June 2020, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  240. Cerenkov Luminescence Imaging for Surgical Margins in Radical Prostatectomy: A Surgical Perspective

    Article • Journal of Nuclear Medicine, June 2020, Society of Nuclear Medicine

    Professor Nathan Lawrentschuk

  241. Review of the use of prophylactic drain tubes post‐robotic radical prostatectomy: Dogma or decent practice?

    Article • BJUI Compass, June 2020, Wiley

    Professor Nathan Lawrentschuk

  242. A systematic scoping review of multidisciplinary cancer team and decision-making in the management of men with advanced prostate cancer

    Article • World Journal of Urology, June 2020, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  243. Bacillus Calmette Guérin (BCG) Vaccination use in the Fight Against COVID-19 – What's Old is New Again?

    Article • Future Oncology, May 2020, Taylor & Francis

    Professor Nathan Lawrentschuk

  244. Safety First: Evidence for Delay of Radical Prostatectomy without Use of Androgen Deprivation Therapy During COVID-19

    Article • Future Oncology, May 2020, Taylor & Francis

    Professor Nathan Lawrentschuk

  245. Early Online Attention Can Predict Citation Counts for Urological Publications: The #UroSoMe_Score

    Article • European Urology Focus, May 2020, Elsevier

    Professor Nathan Lawrentschuk

  246. Use of YouTube as a Resource for Surgical Education—Clarity or Confusion

    Article • European Urology Focus, May 2020, Elsevier

    Professor Nathan Lawrentschuk

  247. The cytoreductive prostatectomy in metastatic prostate cancer: what the individual trials are hoping to answer

    Article • BJU International, April 2020, Wiley

    Professor Nathan Lawrentschuk

  248. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

    Article • The Lancet, April 2020, Elsevier

    Dickon Hayne, Professor Nathan Lawrentschuk

  249. Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Me...

    Article • European Urology, April 2020, Elsevier

    Professor Nathan Lawrentschuk

  250. Myth busting patient’s pain: comparing robotic-assisted verses open radical prostatectomies

    Article • Gland Surgery, April 2020, AME Publishing Company

    Professor Nathan Lawrentschuk

  251. Can online support groups address psychological morbidity of cancer patients? An artificial intelligence based investigation of prostate cancer trajectories

    Article • PLOS One, March 2020, PLOS

    Professor Nathan Lawrentschuk

  252. Indirect Comparisons of Efficacy between Combination Approaches in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Network Meta-analysis

    Article • European Urology, March 2020, Elsevier

    Professor Nathan Lawrentschuk

  253. Anterior prostatectomy for the excision of bladder paraganglioma with prostatic invasion: a unique case of partial prostatectomy

    Article • Australian and New Zealand Journal of Surgery, February 2020, Wiley

    Professor Nathan Lawrentschuk

  254. Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross‐sectional study of the additive diagnostic value of gallium‐68 prostate‐specific membrane antigen positron‐emission tomography/computed tomography to multiparametric magnetic re...

    Article • BJU International, February 2020, Wiley

    Professor Nathan Lawrentschuk

  255. Assessment of Intrafraction Motion of the Urinary Bladder Using Magnetic Resonance Imaging (cineMRI)

    Article • Clinical Oncology, February 2020, Elsevier

    Professor Nathan Lawrentschuk

  256. Navigating systemic therapy for metastatic castration-naïve prostate cancer

    Article • World Journal of Urology, January 2020, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  257. Less, not More, Antibiotics Please

    Article • European Urology Focus, January 2020, Elsevier

    Professor Nathan Lawrentschuk

  258. ‘Prostate Cancer' Information on the Internet: Fact or Fiction?

    Article • Current Urology, January 2020, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  259. Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment

    Article • BJU International, December 2019, Wiley

    Professor Nathan Lawrentschuk

  260. Fully robotic retroperitoneal lymph node dissection – a fusion of technologies – a video vignette

    Article • Colorectal Disease, December 2019, Wiley

    Professor Nathan Lawrentschuk

  261. Orthotopic Neobladder Reconstruction: Patient Selection And Perspectives

    Article • Research and Reports in Urology, December 2019, Taylor & Francis

    Professor Nathan Lawrentschuk

  262. A Cost-effectiveness Analysis of Systemic Therapy for Metastatic Hormone-sensitive Prostate Cancer

    Article • European Urology Oncology, November 2019, Elsevier

    Dr Fernando Alarid-Escudero, Professor Nathan Lawrentschuk

  263. Risk stratification and avoiding overtreatment in localized prostate cancer

    Article • Current Opinion in Urology, November 2019, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  264. Urology trial success – get urologists involved early

    Article • BJU International, November 2019, Wiley

    Professor Nathan Lawrentschuk

  265. Prostate‐specific membrane antigen for the surgical oncologist: interpreting expression beyond the prostate

    Article • Australian and New Zealand Journal of Surgery, October 2019, Wiley

    Professor Nathan Lawrentschuk

  266. Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches

    Article • The Journal of Urology, October 2019, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  267. Systematic review: bacterial colonisation of conduits and neobladders—when to test, watch, and treat

    Article • World Journal of Urology, September 2019, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  268. Prostate‐specific membrane antigen‐positron emission tomography/computed tomography (PSMA‐PET/CT)‐guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single‐institution experience and review of the published literature

    Article • BJU International, September 2019, Wiley

    Professor Nathan Lawrentschuk

  269. Near‐infrared spectroscopy in the diagnosis of testicular torsion: valuable modality or waste of valuable time? A systematic review

    Article • Australian and New Zealand Journal of Surgery, September 2019, Wiley

    Professor Nathan Lawrentschuk

  270. Renal Cell Carcinoma Follow-Up - Is it Time to Abandon Ultrasound?

    Article • Current Urology, September 2019, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  271. Going nuclear: it is time to embed the nuclear medicine physician in the prostate cancer multidisciplinary team

    Article • BJU International, July 2019, Wiley

    Professor Nathan Lawrentschuk

  272. A Simplified Frailty Index to Predict Outcomes After Radical Cystectomy

    Article • European Urology Focus, July 2019, Elsevier

    Professor Nathan Lawrentschuk

  273. Is There an Optimal Curative Option in HIV-Positive Men with Localized Prostate Cancer? A Systematic Review

    Article • Current Urology, July 2019, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  274. Editorial Comment

    Article • The Journal of Urology, June 2019, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  275. The role of 18F-FDG-PET/CT in evaluating retroperitoneal masses -Keeping your eye on the ball!

    Article • Cancer Imaging, May 2019, Springer Science + Business Media

    Dr Dalveer Singh, Professor Nathan Lawrentschuk

  276. Factors associated with spontaneous stone passage in a contemporary cohort of patients presenting with acute ureteric colic: results from the Multi‐centre cohort study evaluating the role of Inflammatory Markers In patients presenting with acute u...

    Article • BJU International, May 2019, Wiley

    Dickon Hayne, Professor Nathan Lawrentschuk

  277. Declining use of radical prostatectomy and pelvic lymphadenectomy despite more robotics: National population data over 15 years

    Article • Asia-Pacific Journal of Clinical Oncology, May 2019, Wiley

    Professor Nathan Lawrentschuk

  278. Rare and less common tumours: urologists at the forefront of testicular and penile cancer

    Article • BJU International, May 2019, Wiley

    Professor Nathan Lawrentschuk

  279. Gender bias in sexual health education: why boys do not know where the prostate is?

    Article • Australian and New Zealand Journal of Surgery, April 2019, Wiley

    Professor Nathan Lawrentschuk

  280. Adverse impact of malnutrition markers on major abdominopelvic cancer surgery

    Article • Australian and New Zealand Journal of Surgery, April 2019, Wiley

    Professor Nathan Lawrentschuk

  281. Robotic Assisted Radical Cystectomy vs Open Radical Cystectomy: Systematic Review and Meta-Analysis

    Article • The Journal of Urology, April 2019, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  282. The use of tissue fiducial markers in improving the accuracy of post-prostatectomy radiotherapy

    Article • Radiation Oncology Journal, March 2019, Korean Society for Therapeutic Radiology and Oncology (KAMJE)

    Professor Nathan Lawrentschuk

  283. High dose rate brachytherapy boost for prostate cancer: Biochemical control and the impact of transurethral resection of the prostate and hydrogel spacer insertion on toxicity outcomes

    Article • Journal of Medical Imaging and Radiation Oncology, March 2019, Wiley

    Professor Nathan Lawrentschuk

  284. Erectile dysfunction: a global review of intracavernosal injectables

    Article • World Journal of Urology, March 2019, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  285. Primary transitional cell carcinoma of penis – A rare presentation

    Article • Urology Case Reports, March 2019, Elsevier

    Professor Nathan Lawrentschuk

  286. Alvimopan for post-radical cystectomy ileus: what should we know?

    Article • Translational Andrology and Urology, March 2019, AME Publishing Company

    Professor Nathan Lawrentschuk

  287. Where to Next for Theranostics in Prostate Cancer?

    Article • European Urology Oncology, March 2019, Elsevier

    Professor Nathan Lawrentschuk

  288. Men’s health on the web: an analysis of current resources

    Article • World Journal of Urology, February 2019, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  289. Editorial Comment

    Article • The Journal of Urology, January 2019, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  290. Improving rectal dosimetry for patients with intermediate and high-risk prostate cancer undergoing combined high-dose-rate brachytherapy and external beam radiotherapy with hydrogel space

    Article • Journal of Contemporary Brachytherapy, January 2019, Termedia Sp. z.o.o.

    Professor Nathan Lawrentschuk

  291. Photoselective Vaporization of the Bladder for the Management of Radiation Cystitis—Technique and Initial Outcomes

    Article • Urology, January 2019, Elsevier

    Professor Nathan Lawrentschuk

  292. Quality of Health Information on the Internet for Prostate Cancer

    Article • Advances in Urology, December 2018, Hindawi Publishing Corporation

    Professor Nathan Lawrentschuk

  293. Robotic-assisted vs. open radical prostatectomy: A machine learning framework for intelligent analysis of patient-reported outcomes from online cancer support groups

    Article • Urologic Oncology Seminars and Original Investigations, December 2018, Elsevier

    Professor Nathan Lawrentschuk

  294. Current management of radiation cystitis: a review and practical guide to clinical management

    Article • BJU International, November 2018, Wiley

    Professor Nathan Lawrentschuk

  295. Bladder cancer surveillance in patients with spinal cord injuries

    Article • BJU International, November 2018, Wiley

    Professor Nathan Lawrentschuk

  296. Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer

    Article • European Urology, November 2018, Elsevier

    Dr Fernando Alarid-Escudero, Professor Nathan Lawrentschuk

  297. Drowning in ethics for low‐risk data: is this best for patients?

    Article • BJU International, November 2018, Wiley

    Professor Nathan Lawrentschuk

  298. Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy

    Article • European Urology, November 2018, Elsevier

    Professor Nathan Lawrentschuk

  299. PSMA PET applications in the prostate cancer journey: from diagnosis to theranostics

    Article • World Journal of Urology, October 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  300. Penile cancer information on the internet: a needle in a haystack

    Article • BJU International, October 2018, Wiley

    Professor Nathan Lawrentschuk

  301. TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II

    Article • BMC Cancer, October 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  302. Analysis of social media use among Australian and New Zealand otolaryngologists

    Article • Australian and New Zealand Journal of Surgery, October 2018, Wiley

    Professor Nathan Lawrentschuk

  303. Machine learning to support social media empowered patients in cancer care and cancer treatment decisions

    Article • PLOS One, October 2018, PLOS

    Professor Nathan Lawrentschuk, Professor Richard John Gray

  304. ASO Author Reflections: Enabling Optimised Delivery of Patient-Centred Cancer Care Using Artificial Intelligence and Data Analytics

    Article • Annals of Surgical Oncology, October 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  305. Fiducial markers: can the urologist do better?

    Article • World Journal of Urology, October 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  306. Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial

    Article • European Urology, October 2018, Elsevier

    Professor Nathan Lawrentschuk

  307. The use of hydrogel spacer in men undergoing high-dose prostate cancer radiotherapy: results of a prospective phase 2 clinical trial

    Article • World Journal of Urology, September 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  308. Analysis of a practical surgical skills laboratory for nerve sparing radical prostatectomy

    Article • World Journal of Urology, September 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  309. Correspondence from specialist surgical outpatient clinics to general practitioners

    Article • Australian and New Zealand Journal of Surgery, September 2018, Wiley

    Damien Bolton, Professor Nathan Lawrentschuk

  310. Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE): a cost minimisation analysis

    Article • World Journal of Urology, August 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  311. Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations

    Article • Prostate Cancer and Prostatic Diseases, August 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  312. Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis

    Article • World Journal of Urology, August 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  313. Accuracy of the magnetic resonance imaging pathway in the detection of prostate cancer: a systematic review and meta-analysis

    Article • Prostate Cancer and Prostatic Diseases, August 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  314. Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer

    Article • Nature Reviews Urology, August 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  315. Editorial Comment

    Article • The Journal of Urology, August 2018, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  316. Editorial Comment

    Article • The Journal of Urology, August 2018, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  317. Landmarks in prostate cancer

    Article • Nature Reviews Urology, July 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  318. Finasteride does not prevent bladder cancer: A secondary analysis of the Medical Therapy for Prostatic Symptoms Study

    Article • Urologic Oncology Seminars and Original Investigations, July 2018, Elsevier

    Professor Nathan Lawrentschuk

  319. Towards gender diversity in urological leadership

    Article • Nature Reviews Urology, June 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  320. Intra‐operative cell salvage in urological surgery: a systematic review and meta‐analysis of comparative studies

    Article • BJU International, June 2018, Wiley

    Professor Nathan Lawrentschuk

  321. A prospective randomized multicentre study of the impact of gallium‐68 prostate‐specific membrane antigen (PSMA) PET/CT imaging for staging high‐risk prostate cancer prior to curative‐intent surgery or radiotherapy (proPSMA study): clinical trial protocol

    Article • BJU International, June 2018, Wiley

    Professor Nathan Lawrentschuk

  322. Incorporating Biomarkers into the Primary Prostate Biopsy Setting: A Cost-Effectiveness Analysis

    Article • The Journal of Urology, June 2018, Elsevier

    Dr Fernando Alarid-Escudero, Professor Nathan Lawrentschuk

  323. Trans-Urethral Snare of Bladder Tumor (TUSnBT) with Stone Basket Retrieval: A Novel Time-Saving Technique in the Endoscopic Management of Papillary Bladder Lesions

    Article • Current Urology, June 2018, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  324. CATCH-22: a manual bladder washout protocol to improve care for clot retention

    Article • World Journal of Urology, May 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  325. Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Locally Advanced, Recurrent, and Metastatic Prostate Cancer

    Article • JAMA Oncology, May 2018, American Medical Association (AMA)

    Professor Nathan Lawrentschuk

  326. Time to link compensation to best practice?

    Article • BJU International, May 2018, Wiley

    Professor Nathan Lawrentschuk

  327. Xp11 translocation renal cell carcinoma paraneoplastic syndrome presenting as cutaneous vasculitis: first reported case of yet another mask

    Article • BMJ Case Reports, April 2018, BMJ

    Professor Nathan Lawrentschuk

  328. Single-use disposable digital flexible ureteroscopes: an ex vivo assessment and cost analysis

    Article • BJU International, April 2018, Wiley

    Damien Bolton, Professor Nathan Lawrentschuk

  329. Prospective analysis of hydrogel spacer for patients with prostate cancer undergoing radiotherapy

    Article • BJU International, April 2018, Wiley

    Professor Nathan Lawrentschuk

  330. PSMA-PET guided hook-wire localization of nodal metastases in prostate cancer: a targeted approach

    Article • World Journal of Urology, April 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  331. Exploring pathways towards improving patient experience of robot-assisted radical prostatectomy (RARP): assessing patient satisfaction and attitudes

    Article • BJU International, March 2018, Wiley

    Caroline Bulsara, Damien Bolton, Bradley Reynolds, Professor Nathan Lawrentschuk

  332. Knowledge of smoking as a risk factor for disease among urology clinic patients in Australia

    Article • World Journal of Urology, March 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  333. Evolution of technologies in urology: full steam ahead?

    Article • World Journal of Urology, March 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  334. Survival outcomes of younger men (< 55 years) undergoing radical prostatectomy

    Article • Prostate International, March 2018, Elsevier

    Professor Nathan Lawrentschuk

  335. Carbon Footprint in Flexible Ureteroscopy: A Comparative Study on the Environmental Impact of Reusable and Single-Use Ureteroscopes

    Article • Journal of Endourology, March 2018, Mary Ann Liebert Inc

    Professor Nathan Lawrentschuk

  336. Health information quality on the internet for bladder cancer and urinary diversion: a multi-lingual analysis

    Article • Minerva Urology and Nephrology, March 2018, Edizioni Minerva Medica

    Professor Nathan Lawrentschuk

  337. Reporting and ideal testosterone levels in men undergoing androgen deprivation for prostate cancer—time for a rethink?

    Article • Prostate International, March 2018, Elsevier

    Professor Nathan Lawrentschuk

  338. Radiotherapy-related complications presenting to a urology department: a more common problem than previously thought?

    Article • BJU International, February 2018, Wiley

    Damien Bolton, Professor Nathan Lawrentschuk

  339. The Patient-Reported Information Multidimensional Exploration (PRIME) Framework for Investigating Emotions and Other Factors of Prostate Cancer Patients with Low Intermediate Risk Based on Online Cancer Support Group Discussions

    Article • Annals of Surgical Oncology, February 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  340. Miniaturised percutaneous nephrolithotomy versus flexible ureteropyeloscopy: a systematic review and meta-analysis comparing clinical efficacy and safety profile

    Article • World Journal of Urology, February 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  341. Prostatic artery embolization for benign prostatic obstruction: assessment of safety and efficacy

    Article • World Journal of Urology, February 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  342. Three dimensional models in uro-oncology: a future built with additive fabrication

    Article • World Journal of Urology, January 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  343. 68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review

    Article • World Journal of Urology, January 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  344. Ureteral intramural metastatic deposit of prostate cancer with ureteric obstruction

    Article • BMJ Case Reports, January 2018, BMJ

    Professor Nathan Lawrentschuk

  345. Magnetic resonance imaging cognitive fusion biopsy – is near enough good enough?

    Article • BJU International, January 2018, Wiley

    Professor Nathan Lawrentschuk

  346. A single institution analysis of low-dose-rate brachytherapy: 5-year reported survival and late toxicity outcomes

    Article • Journal of Contemporary Brachytherapy, January 2018, Termedia Sp. z.o.o.

    Professor Nathan Lawrentschuk

  347. Biomaterials and Regenerative Medicine in Urology

    Article • January 2018, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  348. Increased burden on metropolitan urological services: The era of the Australian National Emergency Access Targets (NEAT or the “4-h target”)

    Article • Urology Annals, January 2018, Medknow

    Professor Nathan Lawrentschuk

  349. Interpreting Prostate Multiparametric Magnetic Resonance Imaging: Urologists' Guide Including Prostate Imaging Reporting and Data System

    Article • Urology, January 2018, Elsevier

    Professor Nathan Lawrentschuk

  350. Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review

    Article • European Urology, January 2018, Elsevier

    Professor Nathan Lawrentschuk

  351. Trends in percutaneous renal biopsy: The evolving diagnostic pathway for the small renal mass

    Article • Urology Annals, January 2018, Medknow

    Professor Nathan Lawrentschuk

  352. Strategies for success: a multi-institutional study on robot-assisted partial nephrectomy for complex renal lesions

    Article • BJU International, December 2017, Wiley

    Damien Bolton, Professor Nathan Lawrentschuk

  353. ‘Prostate Cancer Risk Calculator’ mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS)

    Article • World Journal of Urology, December 2017, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  354. 68 Ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: Current state and future trends

    Article • Prostate International, December 2017, Elsevier

    Professor Nathan Lawrentschuk

  355. Single-use flexible ureteropyeloscopy: a systematic review

    Article • World Journal of Urology, November 2017, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  356. Quality of handwritten surgical operative notes from surgical trainees: a noteworthy issue

    Article • Australian and New Zealand Journal of Surgery, November 2017, Wiley

    Damien Bolton, Professor Nathan Lawrentschuk

  357. The impact of the global bacille Calmette-Guérin shortage on treatment patterns: population-based data

    Article • BJU International, November 2017, Wiley

    Professor Nathan Lawrentschuk

  358. Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study

    Article • Cancer Causes & Control, November 2017, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  359. Editorial Comment

    Article • The Journal of Urology, November 2017, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  360. The Role of Local Therapy for Oligometastatic Prostate Cancer

    Article • Urologic Clinics of North America, November 2017, Elsevier

    Professor Nathan Lawrentschuk

  361. Urological outcomes in Australia and New Zealand: who's watching?

    Article • BJU International, October 2017, Wiley

    Professor Nathan Lawrentschuk

  362. Prostate cancer post-prostatectomy radiotherapy: CT vs MRI for vesico-urethral anastomosis target delineation

    Article • Radiotherapy and Oncology, October 2017, Elsevier

    Professor Nathan Lawrentschuk

  363. Survival outcomes in elderly men undergoing radical prostatectomy in Australia

    Article • Australian and New Zealand Journal of Surgery, September 2017, Wiley

    Damien Bolton, Professor Nathan Lawrentschuk

  364. Changing face of robot-assisted radical prostatectomy in Melbourne over 12 years

    Article • Australian and New Zealand Journal of Surgery, September 2017, Wiley

    anthony costello, Professor Nathan Lawrentschuk

  365. Atypical Small Acinar Proliferation and High-grade Prostatic Intraepithelial Neoplasia in the Era of Multiparametric Magnetic Resonance Imaging: A Contemporary Review

    Article • Urology, September 2017, Elsevier

    Professor Nathan Lawrentschuk

  366. Editorial Comment

    Article • The Journal of Urology, September 2017, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  367. Age Related Differences in Responsiveness to Sildenafil and Tamsulosin are due to Myogenic Smooth Muscle Tone in the Human Prostate

    Article • Scientific Reports, August 2017, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  368. Is choline‐based PET imaging still relevant in recurrent prostate cancer?

    Article • BJU International, August 2017, Wiley

    Professor Nathan Lawrentschuk

  369. Laparoscopic lens fogging: solving a common surgical problem in standard and robotic laparoscopes via a scientific model

    Article • Surgical Endoscopy, August 2017, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  370. The phytological future of prostate cancer staging: prostate-specific membrane antigen positron emission tomography and the dandelion theory

    Article • Future Oncology, August 2017, Future Medicine

    Professor Nathan Lawrentschuk

  371. Ejaculatory frequency and the risk of aggressive prostate cancer: Findings from a case-control study

    Article • Urologic Oncology Seminars and Original Investigations, August 2017, Elsevier

    Professor Nathan Lawrentschuk

  372. Delivery of intracavernosal therapies using needle-free injection devices

    Article • International Journal of Impotence Research, July 2017, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  373. An objective measurement of urinary continence recovery with pelvic floor physiotherapy following robotic assisted radical prostatectomy

    Article • Translational Andrology and Urology, July 2017, AME Publishing Company

    Professor Nathan Lawrentschuk

  374. Optimising patient outcomes with photoselective vaporization of the prostate (PVP): a review

    Article • Translational Andrology and Urology, July 2017, AME Publishing Company

    Professor Nathan Lawrentschuk

  375. Risk factors for Gleason Score upgrading following radical prostatectomy

    Article • Minerva Urology and Nephrology, July 2017, Edizioni Minerva Medica

    Professor Nathan Lawrentschuk

  376. Prostate-specific membrane antigen radioguided surgery: a promising utility

    Article • BJU International, June 2017, Wiley

    Professor Nathan Lawrentschuk

  377. Response to Re: Interns’ perceptions of exposure to urology during medical school education in Victoria, Australia

    Article • Australian and New Zealand Journal of Surgery, June 2017, Wiley

    Damien Bolton, Professor Nathan Lawrentschuk

  378. Minimally invasive surgical therapies for benign prostatic hypertrophy: The rise in minimally invasive surgical therapies

    Article • Prostate International, June 2017, Elsevier

    Professor Nathan Lawrentschuk

  379. Penile Cancer: Contemporary Lymph Node Management

    Article • The Journal of Urology, June 2017, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  380. Transperineal prostate biopsy - tips for analgesia

    Article • BJU International, May 2017, Wiley

    Damien Bolton, Professor Nathan Lawrentschuk

  381. Prognostic microRNAs in upper tract urothelial carcinoma: multicenter and international validation study

    Article • Oncotarget, May 2017, Impact Journals, LLC

    Professor Nathan Lawrentschuk

  382. Thoracic Surgery Information on the Internet: A Multilingual Quality Assessment

    Article • Interactive Journal of Medical Research, May 2017, JMIR Publications Inc.

    Professor Nathan Lawrentschuk

  383. Bladder cancer‐ time for a higher profile in our region

    Article • BJU International, May 2017, Wiley

    Professor Nathan Lawrentschuk

  384. Citation indices for social media articles in urology

    Article • BJU International, May 2017, Wiley

    Professor Nathan Lawrentschuk

  385. Total and beverage-specific alcohol intake and the risk of aggressive prostate cancer: a case–control study

    Article • Prostate Cancer and Prostatic Diseases, April 2017, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  386. Erratum to: Robotic radical cystectomy: technical tips and tricks

    Article • Journal of Robotic Surgery, April 2017, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  387. Visual Occlusion During Minimally Invasive Surgery: A Contemporary Review of Methods to Reduce Laparoscopic and Robotic Lens Fogging and Other Sources of Optical Loss

    Article • Journal of Endourology, April 2017, Mary Ann Liebert Inc

    Professor Nathan Lawrentschuk

  388. Diabetes and elevated urea level predict for uretero-ileal stricture after radical cystectomy and ileal conduit formation

    Article • Canadian Urological Association Journal, March 2017, Canadian Urological Association Journal

    Professor Nathan Lawrentschuk

  389. Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial

    Article • BJU International, March 2017, Wiley

    Professor Nathan Lawrentschuk

  390. Trends in the surgical treatment of benign prostatic hyperplasia in a tertiary hospital

    Article • Australian and New Zealand Journal of Surgery, March 2017, Wiley

    Professor Nathan Lawrentschuk

  391. Reply to Fabio Zattoni, Filiberto Zattoni, and Laura Evangelista's Letter to the Editor re: Marlon Perera, Nathan Papa, Daniel Christidis, et al. Sensitivity, Specificity, and Predictors of Positive 68 Ga–Prostate-specific Membrane Antigen Positron Emi...

    Article • European Urology, February 2017, Elsevier

    Professor Nathan Lawrentschuk

  392. Utility of 68Ga prostate specific membrane antigen – positron emission tomography in diagnosis and response assessment of recurrent renal cell carcinoma

    Article • Journal of Medical Imaging and Radiation Oncology, January 2017, Wiley

    Professor Nathan Lawrentschuk

  393. Bringing clarity or confusion? The role of prostate‐specific membrane antigen positron‐emission/computed tomography for primary staging in prostate cancer

    Article • BJU International, January 2017, Wiley

    Professor Nathan Lawrentschuk

  394. ‘ProtecTion’ from overtreatment: does a randomized trial finally answer the key question in localized prostate cancer?

    Article • BJU International, January 2017, Wiley

    Professor Nathan Lawrentschuk

  395. “Plug and Play”: a novel technique utilising existing technology to get the most out of the robot

    Article • Journal of Robotic Surgery, January 2017, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  396. Health on the Net: Do Website Searches Return Reliable Health Information on Hemorrhoids and Their Treatment?

    Article • International Surgery, January 2017, International College of Surgeons

    Professor Nathan Lawrentschuk

  397. Interns’ perceptions of exposure to urology during medical school education in Victoria, Australia

    Article • Australian and New Zealand Journal of Surgery, January 2017, Wiley

    Professor Nathan Lawrentschuk

  398. Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma

    Article • Investigative and Clinical Urology, January 2017, The Korean Urological Association (KAMJE)

    Professor Nathan Lawrentschuk

  399. Robotic Prostatectomy Delivers on the Promise of Minimally Invasive Surgery

    Article • Urology, January 2017, Elsevier

    Professor Nathan Lawrentschuk

  400. Pain relief after triamcinolone infiltration in patients with bladder pain syndrome with Hunner’s ulcers

    Article • International Urogynecology Journal, December 2016, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  401. Predicting the risk of positive surgical margins following robotic-assisted radical prostatectomy

    Article • Minerva Urology and Nephrology, December 2016, Edizioni Minerva Medica

    Professor Nathan Lawrentschuk

  402. Contrast Enhanced Ultrasonography in suspected renal colic: response

    Article • European Journal of Emergency Medicine, December 2016, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  403. Primary care follow-up of radical prostatectomy patients: A regional New Zealand experience

    Article • Prostate International, December 2016, Elsevier

    Professor Nathan Lawrentschuk

  404. Prostate cancer biomarkers: Are we hitting the mark?

    Article • Prostate International, December 2016, Elsevier

    Professor Nathan Lawrentschuk

  405. Prostate cancer screening with prostate-specific antigen: A guide to the guidelines

    Article • Prostate International, December 2016, Elsevier

    Professor Nathan Lawrentschuk

  406. Reply to Filippo Alongi, Rosario Mazzola, Sergio Fersino's Letter to the Editor re: Patrick C. Walsh, Nathan Lawrentschuk. Immediate Adjuvant Radiation Therapy Following Radical Prostatectomy Should Not Be Advised for Men with Extraprostatic Extension ...

    Article • European Urology, December 2016, Elsevier

    Professor Nathan Lawrentschuk

  407. Sensitivity, Specificity, and Predictors of Positive 68 Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis

    Article • European Urology, December 2016, Elsevier

    Professor Nathan Lawrentschuk

  408. Benefit from cytoreductive nephrectomy and the prognostic role of neutrophil‐to‐lymphocyte ratio in patients with metastatic renal cell carcinoma

    Article • Internal Medicine Journal, November 2016, Wiley

    Professor Nathan Lawrentschuk

  409. Editorial Comment

    Article • The Journal of Urology, November 2016, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  410. Urolithiasis Treatment in Australia: The Age of Ureteroscopic Intervention

    Article • Journal of Endourology, November 2016, Mary Ann Liebert Inc

    Professor Nathan Lawrentschuk

  411. Multiparametric magnetic resonance imaging for prostate cancer—a comparative study including radical prostatectomy specimens

    Article • World Journal of Urology, October 2016, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  412. Volume-outcome relationship in penile cancer treatment: a population based patterns of care and outcomes study from Australia

    Article • BJU International, October 2016, Wiley

    Associate Professor Manish I Patel, Professor Nathan Lawrentschuk

  413. Understanding the role of new systemic agents in the treatment of prostate cancer

    Article • BJU International, October 2016, Wiley

    Professor Nathan Lawrentschuk

  414. A Systematic Review of Ileal Conduit and Neobladder Outcomes in Primary Bladder Cancer

    Article • Urology, October 2016, Elsevier

    Professor Nathan Lawrentschuk

  415. Collaboration is the key for urology

    Article • BJU International, October 2016, Wiley

    Professor Nathan Lawrentschuk

  416. “Collaboration Through Communication”: The Young Urology Researchers Organisation (YURO)

    Article • BJU International, October 2016, Wiley

    Professor Nathan Lawrentschuk

  417. Spontaneous renal calyceal and ureteric rupture secondary to intravenous contrast during computed tomography intravenous pyelogram

    Article • BMJ Case Reports, September 2016, BMJ

    Professor Nathan Lawrentschuk

  418. An update on focal therapy for prostate cancer

    Article • Nature Reviews Urology, September 2016, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  419. Cytoreductive surgery for men with metastatic prostate cancer

    Article • Prostate International, September 2016, Elsevier

    Professor Nathan Lawrentschuk

  420. Management of men with previous negative prostate biopsy

    Article • Current Opinion in Urology, September 2016, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  421. The impact of the United States Preventive Services Task Force (USPTSTF) recommendations against prostate‐specific antigen (PSA) testing on PSA testing in Australia

    Article • BJU International, August 2016, Wiley

    Professor Nathan Lawrentschuk

  422. Contemporary Accuracy of Digital Abdominal X-Ray for Follow-Up of Pure Calcium Urolithiasis: Is There Still a Role?

    Article • Journal of Endourology, August 2016, Mary Ann Liebert Inc

    Professor Nathan Lawrentschuk

  423. Prostate Imaging Reporting and Data System score of four or more: active surveillance no more

    Article • BJU International, July 2016, Wiley

    Professor Nathan Lawrentschuk

  424. Clinical fellows: valuable or not? Opinions of Australian and New Zealand urology trainees and consultants

    Article • Australian and New Zealand Journal of Surgery, July 2016, Wiley

    Professor Nathan Lawrentschuk

  425. Active surveillance in intermediate risk prostate cancer: is it safe?

    Article • International braz j urol, June 2016, FapUNIFESP (SciELO)

    Professor Nathan Lawrentschuk

  426. Testicular torsion and the acute scrotum: current emergency management

    Article • European Journal of Emergency Medicine, June 2016, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  427. Evaluation of pelvic floor muscle strength before and after robotic-assisted radical prostatectomy and early outcomes on urinary continence

    Article • Journal of Robotic Surgery, May 2016, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  428. Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review

    Article • World Journal of Urology, April 2016, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  429. Acute urinary retention and the difficult catheterization

    Article • European Journal of Emergency Medicine, April 2016, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  430. Developing and evaluating Robocare; an innovative, nurse-led robotic prostatectomy care pathway

    Article • European Journal of Oncology Nursing, April 2016, Elsevier

    Professor Nathan Lawrentschuk

  431. Corrigendum

    Article • BJU International, April 2016, Wiley

    Professor Nathan Lawrentschuk

  432. PSA testing and early management of test‐detected prostate cancer‐ consensus at last

    Article • BJU International, April 2016, Wiley

    Professor Nathan Lawrentschuk

  433. Australian patterns of prostate cancer care: Are they evolving?

    Article • Prostate International, March 2016, Elsevier

    Professor Nathan Lawrentschuk

  434. Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose–response relationship

    Article • Radiotherapy and Oncology, March 2016, Elsevier

    Professor Nathan Lawrentschuk

  435. Incidental prostate cancer in transurethral resection of prostate specimens in men aged up to 65 years

    Article • Prostate International, March 2016, Elsevier

    Professor Nathan Lawrentschuk

  436. Immediate Adjuvant Radiation Therapy Following Radical Prostatectomy Should Not Be Advised for Men with Extraprostatic Extension Who Have Negative Surgical Margins

    Article • European Urology, February 2016, Elsevier

    Professor Nathan Lawrentschuk

  437. Renal colic

    Article • European Journal of Emergency Medicine, February 2016, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  438. Guideline of guidelines: follow‐up after nephrectomy for renal cell carcinoma

    Article • BJU International, January 2016, Wiley

    Professor Nathan Lawrentschuk

  439. Prevention of sepsis prior to prostate biopsy

    Article • Investigative and Clinical Urology, January 2016, XMLink

    Professor Nathan Lawrentschuk

  440. Prostate cancer nodal oligometastasis accurately assessed using prostate-specific membrane antigen positron emission tomography-computed tomography and confirmed histologically following robotic-assisted lymph node dissection

    Article • Urology Annals, January 2016, Medknow

    Professor Nathan Lawrentschuk

  441. Quality of Health Information on the Internet for Urolithiasis on the Google Search Engine

    Article • Advances in Urology, January 2016, Wiley

    Professor Nathan Lawrentschuk

  442. Radiation dosing in the investigation and follow-up of urolithiasis: Comparison between historical and contemporary practices

    Article • Investigative and Clinical Urology, January 2016, The Korean Urological Association (KAMJE)

    Professor Nathan Lawrentschuk

  443. Updates of prostate cancer staging: Prostate-specific membrane antigen

    Article • Investigative and Clinical Urology, January 2016, The Korean Urological Association (KAMJE)

    Professor Nathan Lawrentschuk

  444. Vancomycin resistant enterococci in urine cultures: Antibiotic susceptibility trends over a decade at a tertiary hospital in the United Kingdom

    Article • Investigative and Clinical Urology, January 2016, The Korean Urological Association (KAMJE)

    Professor Nathan Lawrentschuk

  445. Radiation delivered to patients during endourological surgery – are they overexposed?

    Article • Journal of Clinical Urology, December 2015, SAGE Publications

    Professor Nathan Lawrentschuk

  446. Magnetic resonance imaging for prostate cancer: Comparative studies including radical prostatectomy specimens and template transperineal biopsy

    Article • Prostate International, December 2015, Elsevier

    Professor Nathan Lawrentschuk

  447. Candidagrowth in urine cultures: a contemporary analysis of species and antifungal susceptibility profiles

    Article • QJM, November 2015, Oxford University Press (OUP)

    Professor Nathan Lawrentschuk

  448. Gleason pattern 4: active surveillance no more

    Article • BJU International, October 2015, Wiley

    Professor Nathan Lawrentschuk

  449. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years

    Article • World Journal of Urology, October 2015, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  450. Incidence and risk factors of venous thromboembolism after pelvic uro‐oncologic surgery – a single center experience

    Article • BJU International, October 2015, Wiley

    Professor Nathan Lawrentschuk

  451. Brachytherapy: state-of-the-art radiotherapy in prostate cancer

    Article • BJU International, October 2015, Wiley

    Professor Nathan Lawrentschuk

  452. Patterns‐of‐care and health economic analysis of robot‐assisted radical prostatectomy in the Australian public health system

    Article • BJU International, October 2015, Wiley

    Professor Nathan Lawrentschuk

  453. Fellowships: more not less to improve employability and patient outcomes

    Article • BJU International, October 2015, Wiley

    Professor Nathan Lawrentschuk

  454. The Career Medical Interview: solid selector or just ‘impression management’?

    Article • BJU International, October 2015, Wiley

    Professor Nathan Lawrentschuk

  455. Response to “Twitter-Based Journal Clubs: Some Additional Facts and Clarifications”

    Article • Journal of Medical Internet Research, September 2015, JMIR Publications Inc.

    Professor Nathan Lawrentschuk

  456. Female urinary incontinence health information quality on the Internet: a multilingual evaluation

    Article • International Urogynecology Journal, September 2015, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  457. The role of cystectomy in elderly patients – a multicentre analysis

    Article • BJU International, September 2015, Wiley

    Professor Nathan Lawrentschuk

  458. Increased prostate cancer specific mortality following radical prostatectomy in men presenting with voiding symptoms—A whole of population study

    Article • Prostate International, September 2015, Elsevier

    Professor Nathan Lawrentschuk

  459. What Are the Predictive Factors for Gleason Score Upgrade following RP?

    Article • Urologia Internationalis, August 2015, Karger Publishers

    Professor Nathan Lawrentschuk

  460. Patterns of care for metastatic renal cell carcinoma in Australia

    Article • BJU International, July 2015, Wiley

    Professor Nathan Lawrentschuk

  461. A Whole of Population, Multiuser Series of High-Intensity Focused Ultrasound for Management of Localized Prostate Cancer: Outcomes and Implications

    Article • Journal of Endourology, July 2015, Mary Ann Liebert Inc

    Professor Nathan Lawrentschuk

  462. Online and social media presence of Australian and New Zealand urologists

    Article • BJU International, June 2015, Wiley

    Professor Nathan Lawrentschuk

  463. Emerging trends in prostate cancer literature: medical progress or marketing hype?

    Article • BJU International, June 2015, Wiley

    Professor Nathan Lawrentschuk

  464. Supervisor volume affects oncological outcomes of trainees performing open radical prostatectomy

    Article • Australian and New Zealand Journal of Surgery, April 2015, Wiley

    Professor Nathan Lawrentschuk

  465. Globalization of Continuing Professional Development by Journal Clubs via Microblogging: A Systematic Review

    Article • Journal of Medical Internet Research, April 2015, JMIR Publications Inc.

    Professor Nathan Lawrentschuk

  466. Consistency of written post-operative patient information for common urological procedures

    Article • Australian and New Zealand Journal of Surgery, April 2015, Wiley

    Professor Nathan Lawrentschuk

  467. Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound-guided biopsy: the Victorian Transperineal Biopsy Collaboration experience

    Article • BJU International, April 2015, Wiley

    Professor Mark Frydenberg, Professor Nathan Lawrentschuk

  468. Altered significance of D'Amico risk classification in patients with prostate cancer linked to a familial breast cancer (kConFab) cohort

    Article • BJU International, April 2015, Wiley

    Damien Bolton, Professor Nathan Lawrentschuk

  469. The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the Victorian Prostate Cancer Registry

    Article • BJU International, April 2015, Wiley

    Professor Mark Frydenberg, Professor Nathan Lawrentschuk

  470. Imaging in prostate cancer with multiparametric magnetic resonance imaging and gallium positron emission tomography‐computed tomography: ‘the real deal'?

    Article • BJU International, April 2015, Wiley

    Professor Nathan Lawrentschuk

  471. Patients with medical risk factors for chronic kidney disease are at increased risk of renal impairment despite the use of nephron-sparing surgery

    Article • BJU International, March 2015, Wiley

    Professor Mark Frydenberg, Professor Nathan Lawrentschuk

  472. Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis

    Article • Journal of Antimicrobial Chemotherapy, March 2015, Oxford University Press (OUP)

    Professor Nathan Lawrentschuk

  473. Enhanced Recovery After Surgery protocols for radical cystectomy surgery: review of current evidence and local protocols

    Article • Australian and New Zealand Journal of Surgery, March 2015, Wiley

    Professor Nathan Lawrentschuk

  474. Prostate cancer screening in Primary Health Care: the current state of affairs

    Article • SpringerPlus, February 2015, Springer Science + Business Media

    Professor Mark Frydenberg, Professor Nathan Lawrentschuk

  475. The social media revolution is changing the conference experience: analytics and trends from eight international meetings

    Article • BJU International, January 2015, Wiley

    Professor Nathan Lawrentschuk

  476. Plasmacytoma of the testis in a patient with relapsed and refractory multiple myeloma: Case report and review of the literature

    Article • Urology Annals, January 2015, Medknow

    Professor Nathan Lawrentschuk

  477. Orthotopic neobladder reconstruction

    Article • Urology Annals, January 2015, Medknow

    Professor Nathan Lawrentschuk

  478. Current role of multiparametric magnetic resonance imaging in the management of prostate cancer

    Article • Korean Journal of Urology, January 2015, XMLink

    Professor Nathan Lawrentschuk

  479. National nephrectomy registries: Reviewing the need for population-based data

    Article • Korean Journal of Urology, January 2015, The Korean Urological Association (KAMJE)

    Professor Nathan Lawrentschuk

  480. Looking forward, looking back—10 years in urology

    Article • Nature Reviews Urology, October 2014, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  481. The emerging use of Twitter by urological journals

    Article • BJU International, October 2014, Wiley

    Professor Nathan Lawrentschuk

  482. U rological S ociety of A ustralia and N ew

    Article • BJU International, October 2014, Wiley

    Professor Nathan Lawrentschuk

  483. Time for bi‐national quality audits for Australian and New Zealand urology

    Article • BJU International, October 2014, Wiley

    Professor Nathan Lawrentschuk

  484. The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review

    Article • European Urology, October 2014, Elsevier

    Professor Nathan Lawrentschuk

  485. A Negative Confirmatory Biopsy Among Men on Active Surveillance for Prostate Cancer Does Not Protect Them from Histologic Grade Progression

    Article • European Urology, September 2014, Elsevier

    Professor Nathan Lawrentschuk

  486. Uro‐oncology multidisciplinary meetings at an A ustralian tertiary referral centre – impact on clinical decision‐making and implications for patient inclusion

    Article • BJU International, July 2014, Wiley

    Professor Nathan Lawrentschuk

  487. Lymphadenectomy with radical cystectomy at an Australian tertiary referral institution: time trends and impact on oncological outcomes

    Article • Australian and New Zealand Journal of Surgery, July 2014, Wiley

    Professor Nathan Lawrentschuk

  488. Rural residency and prostate cancer specific mortality: results from the Victorian Radical Prostatectomy Register

    Article • Australian and New Zealand Journal of Public Health, June 2014, Wiley

    Damien Bolton, Professor Nathan Lawrentschuk

  489. Fournier?s gangrene - delayed pedicle flap based upon the anterior abdominal wall

    Article • International braz j urol, June 2014, FapUNIFESP (SciELO)

    Professor Nathan Lawrentschuk

  490. Fragmentation of Transrectal Ultrasound–guided Biopsy Cores Is Influenced by the Method of Specimen Retrieval

    Article • Urology, March 2014, Elsevier

    Professor Nathan Lawrentschuk

  491. Comparison of contemporary methods for estimating prostate tumour volume in pathological specimens

    Article • BJU International, February 2014, Wiley

    Professor Nathan Lawrentschuk

  492. Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy?

    Article • BJU International, February 2014, Wiley

    Dr Jeremy P Grummet, Professor Mark Frydenberg, Professor Nathan Lawrentschuk

  493. Radiation within urology: challenges and triumphs

    Article • BJU International, February 2014, Wiley

    Professor Nathan Lawrentschuk

  494. Fiducial markers and spacers in prostate radiotherapy: current applications

    Article • BJU International, February 2014, Wiley

    Professor Nathan Lawrentschuk

  495. 18F-fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography Aids Staging and Predicts Mortality in Patients With Muscle-invasive Bladder Cancer

    Article • Urology, February 2014, Elsevier

    Professor Nathan Lawrentschuk

  496. Reply

    Article • Urology, February 2014, Elsevier

    Professor Nathan Lawrentschuk

  497. Lessons from two domestic wars: cancer and poverty

    Article • Future Oncology, November 2013, Future Medicine

    Professor Nathan Lawrentschuk

  498. The dilemmas of prostate cancer screening

    Article • The Medical Journal of Australia, November 2013, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Professor Nathan Lawrentschuk

  499. Population-based analysis of prostate-specific antigen (PSA) screening in younger men (<55 years) in Australia

    Article • BJU International, October 2013, Wiley

    Professor Nathan Lawrentschuk

  500. Is Fosfomycin a Potential Treatment Alternative for Multidrug-Resistant Gram-Negative Prostatitis?

    Article • Clinical Infectious Diseases, October 2013, Oxford University Press (OUP)

    Professor Nathan Lawrentschuk

  501. The role of magnetic resonance imaging in the diagnosis and management of prostate cancer

    Article • BJU International, October 2013, Wiley

    Professor Mark Frydenberg, Professor Nathan Lawrentschuk

  502. Metaplastic conditions of the bladder

    Article • BJU International, October 2013, Wiley

    Professor Nathan Lawrentschuk

  503. Editorial

    Article • BJU International, October 2013, Wiley

    Professor Nathan Lawrentschuk

  504. Effectiveness of epidural versus alternate analgesia for pain relief after radical prostatectomy and correlation with biochemical recurrence in men with prostate cancer

    Article • Research and Reports in Urology, October 2013, Taylor & Francis

    Professor Nathan Lawrentschuk, Damien Bolton

  505. Transperineal biopsy of the prostate—is this the future?

    Article • Nature Reviews Urology, September 2013, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  506. Gene Expression Profiling of Localized Prostate Cancer: Getting Answers to the Questions That Really Matter

    Article • Journal of Clinical Oncology, September 2013, American Society of Clinical Oncology (ASCO)

    Professor Nathan Lawrentschuk

  507. Should Follow-up Biopsies for Men on Active Surveillance for Prostate Cancer Be Restricted to Limited Templates?

    Article • Urology, August 2013, Elsevier

    Professor Nathan Lawrentschuk

  508. Interval to biochemical recurrence following radical prostatectomy does not affect survival in men with low-risk prostate cancer

    Article • World Journal of Urology, July 2013, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  509. Bladder carcinoma in situ (CIS) in Australia: a rising incidence for an under‐reported malignancy

    Article • BJU International, April 2013, Wiley

    Professor Nathan Lawrentschuk

  510. The role of magnetic resonance imaging in prostate cancer

    Article • Australian and New Zealand Journal of Surgery, April 2013, Wiley

    Professor Nathan Lawrentschuk

  511. Orthotopic Bladder Substitution (Neobladder)

    Article • Journal of Wound Ostomy and Continence Nursing, March 2013, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  512. Current Role of PET, CT, MR for Invasive Bladder Cancer

    Article • Current Urology Reports, February 2013, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  513. Nephrectomy for a Renal Metastasis of Undiagnosed Hepatocellular Carcinoma Arising From an Orthotopic Liver Transplant Undertaken for Cryptogenic Cirrhosis

    Article • Korean Journal of Urology, January 2013, The Korean Urological Association (KAMJE)

    Professor Nathan Lawrentschuk

  514. Orthotopic Bladder Substitution (Neobladder)

    Article • Journal of Wound Ostomy and Continence Nursing, January 2013, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  515. Spermatocytic Seminoma With Sarcoma: An Indication for Adjuvant Chemotherapy in Localized Disease

    Article • Korean Journal of Urology, January 2013, The Korean Urological Association (KAMJE)

    Professor Nathan Lawrentschuk

  516. Urothelial carcinoma of the bladder with asynchronous metastases to both testes

    Article • Urology Annals, January 2013, Medknow

    Professor Nathan Lawrentschuk

  517. A smoking cessation program as a resource for bladder cancer

    Article • Canadian Urological Association Journal, October 2012, Canadian Urological Association Journal

    Professor Nathan Lawrentschuk

  518. Editorial Comment

    Article • The Journal of Urology, September 2012, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  519. PET in Prostate and Bladder Tumors

    Article • Seminars in Nuclear Medicine, July 2012, Elsevier

    Professor Nathan Lawrentschuk

  520. Humour and urology: “Nota bene dick doc”

    Article • Canadian Urological Association Journal, June 2012, Canadian Urological Association Journal

    Professor Nathan Lawrentschuk

  521. Prostatic needle biopsies following primary high intensity focused ultrasound (HIFU) therapy for prostatic adenocarcinoma: histopathological features in tumour and non-tumour tissue

    Article • Journal of Clinical Pathology, June 2012, BMJ

    Professor Nathan Lawrentschuk

  522. Impact of Multiparametric Endorectal Coil Prostate Magnetic Resonance Imaging on Disease Reclassification Among Active Surveillance Candidates: A Prospective Cohort Study

    Article • The Journal of Urology, April 2012, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  523. Saving Nephrons: Current Surgical Options in Partial Nephrectomy

    Article • Journal of Analytical Oncology, January 2012, Neoplasia Research

    Professor Nathan Lawrentschuk

  524. An Investigation of the Basic Physics of Irrigation in Urology and the Role of Automated Pump Irrigation in Cystoscopy

    Article • The Scientific World JOURNAL, January 2012, Hindawi Publishing Corporation

    Professor Nathan Lawrentschuk

  525. Commentary on “Partial orchiectomy for presumed malignancy in patients with a solitary testis due to a prior germ cell tumor: A large North American experience.” Lawrentschuk N, Zuniga A, Grabowksi AC, Rendon RA, Jewett MA, Division of Urology, Departm...

    Article • Urologic Oncology Seminars and Original Investigations, January 2012, Elsevier

    Professor Nathan Lawrentschuk

  526. Effects of Partial Nephrectomy on Postoperative Blood Pressure

    Article • Korean Journal of Urology, January 2012, The Korean Urological Association (KAMJE)

    Professor Nathan Lawrentschuk

  527. Incidence of Bladder Cancer in Sri Lanka: Analysis of the Cancer Registry Data and Review of the Incidence of Bladder Cancer in the South Asian Population

    Article • Korean Journal of Urology, January 2012, The Korean Urological Association (KAMJE)

    Professor Nathan Lawrentschuk

  528. Oncology Health Information Quality on the Internet: a Multilingual Evaluation

    Article • Annals of Surgical Oncology, December 2011, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  529. The pursuit of the “perfect” biomarker in prostate cancer

    Article • Canadian Urological Association Journal, December 2011, Canadian Urological Association Journal

    Professor Nathan Lawrentschuk

  530. Penile lichen sclerosus (balanitis xerotica obliterans)

    Article • BJU International, November 2011, Wiley

    Professor Nathan Lawrentschuk

  531. Re: Salvage Radical Prostatectomy Following Primary High Intensity Focused Ultrasound for Treatment of Prostate Cancer

    Article • The Journal of Urology, September 2011, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  532. Prevention and management of TURP-related hemorrhage

    Article • Nature Reviews Urology, August 2011, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  533. Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and 124I-cG250 PET/CT

    Article • Urologic Oncology Seminars and Original Investigations, July 2011, Elsevier

    Professor Nathan Lawrentschuk

  534. Consumerism and its impact on robotic-assisted radical prostatectomy

    Article • BJU International, June 2011, Wiley

    Professor Nathan Lawrentschuk

  535. Evolution from active surveillance to focal therapy in the management of prostate cancer

    Article • Future Oncology, June 2011, Future Medicine

    Professor Nathan Lawrentschuk

  536. Surgical margin status among men with organ-confined (pT2) prostate cancer: a population-based study

    Article • Canadian Urological Association Journal, June 2011, Canadian Urological Association Journal

    Professor Nathan Lawrentschuk

  537. Active surveillance for low-risk prostate cancer: an update

    Article • Nature Reviews Urology, April 2011, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  538. Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort

    Article • BJU International, April 2011, Wiley

    Professor Nathan Lawrentschuk

  539. Evolution of the USANZ tie

    Article • BJU International, April 2011, Wiley

    Professor Nathan Lawrentschuk

  540. Impact of 5α-Reductase Inhibitors on Men Followed by Active Surveillance for Prostate Cancer

    Article • European Urology, April 2011, Elsevier

    Professor Nathan Lawrentschuk

  541. Lessons learned: end‐user assessment of a skills laboratory based training programme for urology trainees

    Article • BJU International, April 2011, Wiley

    Professor Nathan Lawrentschuk

  542. An analysis of world media reporting of two recent large randomized prospective trials investigating screening for prostate cancer

    Article • BJU International, March 2011, Wiley

    Professor Nathan Lawrentschuk

  543. Efficacy of a Second Line Luteinizing Hormone-Releasing Hormone Agonist After Advanced Prostate Cancer Biochemical Recurrence

    Article • The Journal of Urology, March 2011, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  544. Salvage Radical Prostatectomy Following Primary High Intensity Focused Ultrasound for Treatment of Prostate Cancer

    Article • The Journal of Urology, March 2011, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  545. Partial Orchiectomy for Presumed Malignancy in Patients With a Solitary Testis Due to a Prior Germ Cell Tumor: A Large North American Experience

    Article • The Journal of Urology, February 2011, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  546. Realistic Anatomical Prostate Models for Surgical Skills Workshops Using Ballistic Gelatin for Nerve-Sparing Radical Prostatectomy and Fruit for Simple Prostatectomy

    Article • January 2011, The Korean Urological Association (KAMJE)

    Professor Nathan Lawrentschuk

  547. The Role of Lymph Node Fine-Needle Aspiration in Penile Cancer in the Sentinel Node Era

    Article • Advances in Urology, January 2011, Hindawi Publishing Corporation

    Professor Nathan Lawrentschuk

  548. Recent advances in magnetic resonance imaging of prostate cancer

    Article • F1000 Medicine Reports, December 2010, F1000Research

    Professor Nathan Lawrentschuk

  549. Role of positron emission tomography in urological oncology

    Article • BJU International, November 2010, Wiley

    Professor Nathan Lawrentschuk

  550. Prostate cancer immunology – an update for Urologists

    Article • BJU International, November 2010, Wiley

    Professor Nathan Lawrentschuk

  551. Image guidance for focal therapy of prostate cancer

    Article • World Journal of Urology, October 2010, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  552. Diagnosis of Bone Metastases in Urological Malignancies—An Update

    Article • Urology, October 2010, Elsevier

    Professor Nathan Lawrentschuk

  553. MRI for men undergoing active surveillance or with rising PSA and negative biopsies

    Article • Nature Reviews Urology, October 2010, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  554. Prevention and management of complications following radical cystectomy for bladder cancer

    Article • International braz j urol, October 2010, FapUNIFESP (SciELO)

    Professor Nathan Lawrentschuk

  555. Focal therapy in prostate cancer: modalities, findings and future considerations

    Article • Nature Reviews Urology, September 2010, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  556. [18F]‐fluorocholine positron‐emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study

    Article • BJU International, August 2010, Wiley

    Professor Nathan Lawrentschuk

  557. Organ-sparing approaches for testicular masses

    Article • Nature Reviews Urology, August 2010, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  558. Radical prostatectomy in obese patients: Improved surgical outcomes in recent years

    Article • International Journal of Urology, July 2010, Wiley

    Professor Nathan Lawrentschuk

  559. Construction and Evaluation of an Anatomically Correct Multi-Image Modality Compatible Phantom for Prostate Cancer Focal Ablation

    Article • The Journal of Urology, July 2010, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  560. Creation and Validation of a Visual Macroscopic Hematuria Scale for Optimal Communication and an Objective Hematuria Index

    Article • The Journal of Urology, July 2010, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  561. Cystectomy in Patients With Spinal Cord Injury: Indications and Long-Term Outcomes

    Article • The Journal of Urology, July 2010, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  562. Prostate-specific antigen test result interpretation when combined with risk factors for recommendation of biopsy: a survey of urologist’s practice patterns

    Article • International Urology and Nephrology, June 2010, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  563. Focal Laser Ablation for Prostate Cancer Followed by Radical Prostatectomy: Validation of Focal Therapy and Imaging Accuracy

    Article • European Urology, June 2010, Elsevier

    Professor Nathan Lawrentschuk

  564. Laparoscopic Lens Fogging: A Review of Etiology and Methods to Maintain a Clear Visual Field

    Article • Journal of Endourology, June 2010, Mary Ann Liebert Inc

    Professor Nathan Lawrentschuk

  565. Potential of imaging biomarkers for characterization of renal masses

    Article • Expert Review of Anticancer Therapy, June 2010, Taylor & Francis

    Professor Nathan Lawrentschuk

  566. Prevention and Management of Complications Following Radical Cystectomy for Bladder Cancer

    Article • European Urology, June 2010, Elsevier

    Professor Nathan Lawrentschuk

  567. Re: Polyorchidism: A Meta-Analysis

    Article • The Journal of Urology, June 2010, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  568. Imaging renal cell carcinoma with ultrasonography, CT and MRI

    Article • Nature Reviews Urology, May 2010, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  569. Predicting prostate biopsy outcome: artificial neural networks and polychotomous regression are equivalent models

    Article • International Urology and Nephrology, May 2010, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  570. Focal Laser Ablation for Localized Prostate Cancer

    Article • Journal of Endourology, May 2010, Mary Ann Liebert Inc

    Professor Nathan Lawrentschuk

  571. Functional imaging of renal cell carcinoma

    Article • Nature Reviews Urology, May 2010, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  572. Investigating Contamination of Phytotherapy Products for Benign Prostatic Hyperplasia With α-Blockers and 5α-Reductase Inhibitors

    Article • The Journal of Urology, May 2010, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  573. Re: Radical Prostatectomy Findings in Patients in Whom Active Surveillance of Prostate Cancer Fails

    Article • The Journal of Urology, May 2010, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  574. Tumor Volume in Radical Prostatectomy Specimens Assessed by Digital Image Analysis Software Correlates With Other Prognostic Factors

    Article • The Journal of Urology, May 2010, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  575. ‘Prostatic evasive anterior tumours’: the role of magnetic resonance imaging

    Article • BJU International, April 2010, Wiley

    Professor Nathan Lawrentschuk

  576. Improving informed consent for patients undergoing radical prostatectomy using multimedia techniques: a prospective randomized crossover study

    Article • BJU International, March 2010, Wiley

    Professor Nathan Lawrentschuk

  577. AN INTERACTIVE MULTIMEDIA APPROACH TO UROLOGICAL ANATOMY

    Article • BJU International, March 2010, Wiley

    Professor Nathan Lawrentschuk

  578. Clinical significance of the positive surgical margin based upon location, grade, and stage

    Article • Urologic Oncology Seminars and Original Investigations, March 2010, Elsevier

    Professor Nathan Lawrentschuk

  579. Active Surveillance for Favorable-Risk Prostate Cancer: A Short Review

    Article • January 2010, The Korean Urological Association (KAMJE)

    Professor Nathan Lawrentschuk

  580. Imaging of Bone Metastases

    Article • January 2010, Elsevier

    Professor Nathan Lawrentschuk

  581. Nutraceuticals and prostate cancer prevention: a current review

    Article • Nature Reviews Urology, December 2009, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  582. Operator is an Independent Predictor of Detecting Prostate Cancer at Transrectal Ultrasound Guided Prostate Biopsy

    Article • The Journal of Urology, December 2009, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  583. Urinary catheter balloons should only be filled with water: testing the myth

    Article • BJU International, November 2009, Wiley

    Professor Nathan Lawrentschuk

  584. Editorial Comment

    Article • Urology, November 2009, Elsevier

    Professor Nathan Lawrentschuk

  585. Health Information Quality on the Internet in Urological Oncology: A Multilingual Longitudinal Evaluation

    Article • Urology, November 2009, Elsevier

    Professor Nathan Lawrentschuk

  586. Placenta Percreta With Urinary Tract Involvement: The Case for a Multidisciplinary Approach

    Article • Urology, October 2009, Elsevier

    Professor Nathan Lawrentschuk

  587. Reply

    Article • American Journal of Obstetrics and Gynecology, September 2009, Elsevier

    Professor Nathan Lawrentschuk

  588. Re: Use of a Warming Bath to Prevent Lens Fogging During Laparoscopy

    Article • Journal of Endourology, July 2009, Mary Ann Liebert Inc

    Professor Nathan Lawrentschuk

  589. Clinical stage I seminoma: the case for surveillance

    Article • World Journal of Urology, June 2009, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  590. Risk of Developing Prostate Cancer in the Future: Overview of Prognostic Biomarkers

    Article • Urology, May 2009, Elsevier

    Professor Nathan Lawrentschuk

  591. CURRENT TEXTBOOKS AND ANATOMY OF THE PROSTATE – A CASE FOR AN UPDATE

    Article • BJU International, April 2009, Wiley

    Professor Nathan Lawrentschuk

  592. Draping and associated equipment for indwelling catheter manipulation by hospital staff: an assessment of attitudes and adequacy

    Article • BJU International, April 2009, Wiley

    Professor Nathan Lawrentschuk

  593. The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate‐specific antigen levels

    Article • BJU International, February 2009, Wiley

    Professor Nathan Lawrentschuk

  594. Long-Term Outcomes of External Sphincterotomy in a Spinal Injured Population

    Article • The Journal of Urology, February 2009, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  595. Anatomic Considerations for Radical Retropubic Prostatectomy in an Achondroplastic Dwarf

    Article • The Scientific World JOURNAL, January 2009, Hindawi Publishing Corporation

    Professor Nathan Lawrentschuk

  596. Phosphodiesterase 5 inhibitors in the management of benign prostatic hyperplasia and erectile dysfunction: the best of both worlds

    Article • Current Opinion in Urology, January 2009, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  597. Severe Irritant Contact Dermatitis Causing Skin Ulceration Secondary to a Testosterone Patch

    Article • The Scientific World JOURNAL, January 2009, Hindawi Publishing Corporation

    Professor Nathan Lawrentschuk

  598. Vulvar hematoma secondary to spontaneous rupture of the internal iliac artery: clinical review

    Article • American Journal of Obstetrics and Gynecology, January 2009, Elsevier

    Professor Nathan Lawrentschuk

  599. Re: The Role of Positron Emission Tomography in the Evaluation of Residual Masses After Chemotherapy for Advanced Stage Seminoma

    Article • The Journal of Urology, December 2008, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  600. Peripheral Primitive Neuroectodermal Tumor Arising from the Seminal Vesicle

    Article • Urologia Internationalis, January 2008, Karger Publishers

    Professor Nathan Lawrentschuk

  601. Renal cell carcinoma: imaging and therapy

    Article • Current Opinion in Urology, September 2007, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  602. Submucosal vesical varicosities causing hematuria and retention of urine in pregnancy: cystovarix

    Article • American Journal of Obstetrics and Gynecology, May 2007, Elsevier

    Professor Nathan Lawrentschuk

  603. Renal Cell Cancer and Positron Emission Tomography- an Evolving Diagnostic and Therapeutic Relationship

    Article • Current Medical Imaging Formerly Current Medical Imaging Reviews, February 2007, Bentham Science Publishers

    Professor Nathan Lawrentschuk

  604. Diagnostic and therapeutic use of radioisotopes for bony disease in prostate cancer: Current practice

    Article • International Journal of Urology, January 2007, Wiley

    Professor Nathan Lawrentschuk

  605. Fluorine-18 Fluorothymidine: A New Positron Emission Radioisotope for Renal Tumors

    Article • Clinical Nuclear Medicine, December 2006, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  606. Delineating the anatomy of oncologic postradiation vesicovaginal fistulae with reconstructed computed tomography

    Article • International Urogynecology Journal, November 2006, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  607. Fine‐needle aspiration cytology predicts inguinal lymph node metastasis without antibiotic pretreatment in penile carcinoma

    Article • BJU International, May 2006, Wiley

    Professor Nathan Lawrentschuk

  608. Metachronous metastasis to the penis from carcinoma of the rectum

    Article • International Journal of Urology, May 2006, Wiley

    Professor Nathan Lawrentschuk

  609. Positron emission tomography (PET), immuno‐PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship

    Article • BJU International, April 2006, Wiley

    Professor Nathan Lawrentschuk

  610. Positron emission tomography and molecular imaging of the prostate: an update

    Article • BJU International, April 2006, Wiley

    Professor Nathan Lawrentschuk

  611. Cystoscopy in women with recurrent urinary tract infection

    Article • International Journal of Urology, April 2006, Wiley

    Professor Nathan Lawrentschuk

  612. An analysis of deaths related to urological surgery, reviewed by the State Coroner: a case for cardiac vigilance before transurethral prostatectomy

    Article • BJU International, March 2006, Wiley

    Professor Nathan Lawrentschuk

  613. Renal Cell Carcinoma Following Testicular Cancer: Case Report and Literature Review

    Article • International Urology and Nephrology, February 2006, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  614. Sclerosing Lipogranuloma of the Genitalia Treated with Corticosteroids

    Article • International Urology and Nephrology, February 2006, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  615. Training Model for Open or Laparoscopic Pyeloplasty

    Article • Journal of Endourology, February 2006, Mary Ann Liebert Inc

    Professor Nathan Lawrentschuk

  616. Fixed Drug Eruption of the Penis Secondary to Sulfamethoxazole-Trimethoprim

    Article • The Scientific World JOURNAL, January 2006, Hindawi Publishing Corporation

    Professor Nathan Lawrentschuk

  617. Xenografting Tumour beneath the Renal Capsule Using Modern Surgical Equipment

    Article • European Surgical Research, January 2006, Karger Publishers

    Professor Nathan Lawrentschuk

  618. Peritoneal “pillowcase” for the displaced spleen post-distal pancreatectomy

    Article • Journal of Hepato-Biliary-Pancreatic Surgery, December 2005, Springer Science + Business Media

    Professor Nathan Lawrentschuk

  619. Intraoperative ‘floppy iris’ syndrome and its relationship to tamsulosin: a urologist's guide

    Article • BJU International, December 2005, Wiley

    Professor Nathan Lawrentschuk

  620. Sterile disposable sheath system for flexible cystoscopes

    Article • Urology, December 2005, Elsevier

    Professor Nathan Lawrentschuk

  621. Assessing regional hypoxia in human renal tumours using 18F‐fluoromisonidazole positron emission tomography

    Article • BJU International, August 2005, Wiley

    Professor Nathan Lawrentschuk

  622. Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review

    Article • BJU International, July 2005, Wiley

    Professor Nathan Lawrentschuk

  623. Outcome from percutaneous nephrolithotomy in patients with spinal cord injury, using a single‐stage dilator for access

    Article • BJU International, July 2005, Wiley

    Professor Nathan Lawrentschuk

  624. EFFECTIVENESS OF CYPROTERONE ACETATE IN ACHIEVING CASTRATION AND PREVENTING LUTEINIZING HORMONE RELEASING HORMONE ANALOGUE INDUCED TESTOSTERONE SURGE IN PATIENTS WITH PROSTATE CANCER

    Article • The Journal of Urology, July 2005, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  625. CAUDA EQUINA SYNDROME SECONDARY TO CONSTIPATION: AN UNCOMMON OCCURRENCE

    Article • Australian and New Zealand Journal of Surgery, June 2005, Wiley

    Professor Nathan Lawrentschuk

  626. Inserting testicular prostheses: a new surgical technique for difficult cases

    Article • BJU International, April 2005, Wiley

    Professor Nathan Lawrentschuk

  627. Erratum

    Article • Urology, March 2005, Elsevier

    Professor Nathan Lawrentschuk

  628. Metastatic Breast Cancer to the Bladder

    Article • The Breast Journal, March 2005, Hindawi Publishing Corporation

    Professor Nathan Lawrentschuk

  629. Occult renal segmental arterial injury after trauma

    Article • Urology, February 2005, Elsevier

    Professor Nathan Lawrentschuk

  630. Fenestrated urethral catheter to aid anastomotic drainage after radical prostatectomy

    Article • Urology, January 2005, Elsevier

    Professor Nathan Lawrentschuk

  631. 18F-fluorodeoxyglucose positron emission tomography in evaluation of germ cell tumor after chemotherapy

    Article • Urology, December 2004, Elsevier

    Professor Nathan Lawrentschuk

  632. Polyorchidism: a case report and review of the literature

    Article • Australian and New Zealand Journal of Surgery, December 2004, Wiley

    Professor Nathan Lawrentschuk

  633. Functional imaging of intratumoral hypoxia

    Article • Molecular Imaging and Biology, October 2004, Elsevier

    Professor Nathan Lawrentschuk

  634. Implications of amyloidosis on prostatic biopsy

    Article • International Journal of Urology, October 2004, Wiley

    Professor Nathan Lawrentschuk

  635. Use of holmium laser for removal of an intraluminal ureteric suture

    Article • International Journal of Urology, October 2004, Wiley

    Professor Nathan Lawrentschuk

  636. Suprapubic stab cystostomy

    Article • Urology, July 2004, Elsevier

    Professor Nathan Lawrentschuk

  637. SPONTANEOUS BLADDER WALL ABSCESS

    Article • The Journal of Urology, June 2004, Wolters Kluwer Health

    Professor Nathan Lawrentschuk

  638. Ureteric stenting 25 years on: routine or risky?

    Article • Australian and New Zealand Journal of Surgery, April 2004, Wiley

    Professor Nathan Lawrentschuk

  639. Suprapubic stab cystostomy: a safer technique

    Article • Urology, November 2003, Elsevier

    Professor Nathan Lawrentschuk

  640. ELECTIVE LAPAROSCOPIC CHOLECYSTECTOMY: IMPLICATIONS OF PROLONGED WAITING TIMES FOR SURGERY

    Article • Australian and New Zealand Journal of Surgery, October 2003, Wiley

    Professor Nathan Lawrentschuk

  641. Necrotizing fasciitis: an unusual presentation for rectal carcinoma

    Article • Australian and New Zealand Journal of Surgery, October 2003, Wiley

    Professor Nathan Lawrentschuk

  642. Spontaneous intracerebral haemorrhages—warfarin as a risk factor

    Article • Journal of Clinical Neuroscience, September 2003, Elsevier

    Professor Nathan Lawrentschuk

  643. Testicular microlithiasis: a case report and review of the literature

    Article • Australian and New Zealand Journal of Surgery, May 2003, Wiley

    Professor Nathan Lawrentschuk

  644. Dressing size and pain: A prospective trial

    Article • Australian and New Zealand Journal of Surgery, April 2003, Wiley

    Professor Nathan Lawrentschuk

  645. Percutaneous Transluminal Angioplasty of Stenosis at the Common Iliac Artery Origin Using a Single Balloon Technique

    Article • EJVES Extra, April 2003, Elsevier

    Professor Nathan Lawrentschuk

  646. Wound blisters post hip surgery: A prospective trial comparingdressings

    Article • Australian and New Zealand Journal of Surgery, October 2002, Wiley

    Professor Nathan Lawrentschuk